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Abstract 
The use of skeletal tissues in forensic toxicology research has increased dramatically in the last 5 
years. These studies have yielded valuable information pertinent to using skeletal tissues as a 
biological matrix in drug analysis. The majority of these studies have been completed on a small 
scale so a larger scale is needed for further research. Here, a high throughput microwave assisted 
extraction (MAE) and microplate solid phase extraction (MPSPE) protocol is developed and 
implemented to examine how body position and microclimate affect ketamine and metabolite 
distribution in decomposed skeletal tissue. Analytes were successful recovered in 30 min 
following MAE compared to 180 min for passive solvent extraction (PSE). Body proved to be 
significantly different in the observed drug levels at both microclimates. The sunlit microclimate 
had significantly higher drug levels, with less maggot activity, compared to the shaded 
microclimate. 
Keywords 
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Chapter 1 
1  Introduction 
1.1  Forensic Toxicology 
Forensic toxicology is a branch of forensic science that studies the effects of chemicals on living 
organisms to aid in legal investigations (Levine, 2010). It encompasses principles from other 
disciplines including chemistry, biology and pharmacology. Forensic toxicology consists of three 
subfields: post-mortem toxicology, human performance toxicology and forensic drug testing 
(Levine, 2010).  Post-mortem toxicology is used to aid in the determination of cause of death and 
to diagnosis drug intoxications.  Blood is the most commonly analyzed specimen since drug 
levels can be linked to non-fatal and fatal concentrations. Other specimens used for analysis 
include: urine, hair, liver, vitreous humor, bile and muscle. Skeletal tissues, bone and bone 
marrow, are not typically used in post-mortem analysis; there is no database to correlate drug 
levels with intoxication. In cases of severe decomposition, bone tissue may be the only specimen 
available for collection so it is important to access its potential in post-mortem analyses. 
1.2 Bone Physiology and Drug Deposition in Bone  
The extracellular matrix of bone is composed largely of inorganic materials; the most abundant 
being hydroxyapatite (Ca10 (PO4)6OH2) (Martini et al., 2009). Other inorganic materials include 
salts (calcium carbonate) and ions (sodium, magnesium and fluoride), while the major organic 
material are collagen fibers. The hydroxyapatite crystals form on collagen fibers which provide a 
strong framework for the bone (Martini et al., 2009). Osteocytes are the most abundant bone cell 
type and are responsible for maintaining mineral and protein content for the extracellular matrix, 
as well as repairing damaged bone (Martini et al., 2009). Osteoblasts (cells that build bone 
matrix), osteoclasts (cells that remove and recycle bone matrix) and osteoprogenitor cells (cells 
that produces osteoblasts) are also present. Osteocytes are located in lacunae (pockets layered 
between lamellae). Canaliculi (canals) connect lacunae, through the lamellae, and create a 
pathway to transfer materials between cells (Martini et al., 2009). 
Compact bone is composed of osteons (Haversian system). Within an osteon, osteocytes are 
arranged in coaxial layer around the Haversian canal (central canal) which runs parallel with the 
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length of the bone (Martini et al., 2009). Perforating canals run perpendicular to the bone 
surface. These canals are responsible for transporting materials to the bone. Spongy bone 
contains struts and plates, termed trabeculae, which contain lamellae, osteocytes, lacunae and 
canaliculi (Martini et al., 2009). The trabeculae are adjacent to cavities that contain red bone 
marrow. The canaliculi open onto the surface of the trabeculae and allow the transfer of materials 
to the osteocytes. Short (i.e. carpals) and irregular bones (i.e. Vertebra) contain a thin layer of 
compact bone surround centrally located spongy bone. Long bones (i.e. femur, tibia, and 
humerus) contain compact bone in the diaphysis (midsection of the bone) and spongy bone in the 
epiphysis (rounded end of the bone). Flat bones (i.e. ribs, scapula, and pelvis) contain two thin 
layers of compact bone surrounding spongy bone. 
The degree of drug deposition into bone is heavily influenced by the structural and physiological 
features of the various bones. Differences in bone architecture provide varying degrees of surface 
area for the drugs to make contact (Stempemsky et al., 2003). The various bones have unique 
compositions of cortical and cancellous bone which may provide storage sites for drugs. The 
type of bone marrow (red or yellow) may provide storage sites based upon lipophilicity of the 
drug. These considerations have to lead to three potential mechanism of drug deposition into 
bone. The first mechanism involves the absorption of the drug by the bloodstream into systemic 
circulation, and the subsequent rapid uptake of drugs by the canaliculi which transport them to 
the lacunae (Stepemsky et al., 2003). The second mechanism involves drug transport from 
systemic circulation to the bone marrow. Bone marrow has a rich vascularization, high lipid 
content and encasement within the bone which make it a potential repository for drugs (Cartiser 
et al., 2011). The third mechanism is thought to involve the process of decomposition. During 
decomposition, soft tissues liquefy which results in drug partitioning. The drug-rich fluid may 
then be absorbed by the surrounding bone due to its somewhat porous nature. Additional factors 
that affect drug deposition into bone include: route of administration, distribution at time of 
death and physiochemical characteristics of the drug. 
1.3 Drug Isolation and Preparation Techniques in Bone 
1.3.1 Passive Solvent Extraction 
 Passive solvent extraction (PSE) is based upon diffusion between a solid matrix and a 
liquid solvent. In PSE, heat is transferred to the vessel containing the matrix. The solvent is 
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heated which causes desorption of constituents from the matrix. These constituents diffuse into 
and become dissolved in the bulk solvent. The supernatant is collected and assayed. Parameters 
often influencing PSE include: extraction time, choice of solvent, solvent volume, temperature, 
mass and particle size. Table 1 lists the factors that affect the extraction efficiency of PSE. 
1.3.2 Microwave Assisted Extraction 
The first publications involving extraction of organic compounds using microwave assisted 
extraction (MAE) was published in 1986 by Ganzler, Salgo and Valko (cited in Letellier et al., 
1999). In these studies, the authors developed extraction protocols for lipids, antinutritives and 
pesticides in different matrices; soils, seeds, foods and feeds. More recent studies have examined 
the application of MAE for soils, sediments and hair (Bartolomé et al., 2005; Liu et al., 2004; 
Fernández et al., 2009). Microwaves are a form of electromagnetic radiation, ranging from 300 
MHZ to 300 GHz, composed of oscillating perpendicular magnetic and electric fields (Mandal et 
al., 2007). They are used as both information carriers and energy vectors which transform 
electromagnetic energy into heat as a result of wave adsorption (Mandal et al., 2007).  
Commercial microwaves operate at a frequency of 2450 MHz (Letellier et al., 1999).  
In MAE, microwave radiation is absorbed by the solvent and/or sample, which leads to sample 
heating by two mechanisms: ionic conduction and/or dipole rotation, which usually occur 
simultaneously (Mandal et al., 2007). Ionic conduction occurs as a result of ion migration under 
a changing electric field (Mandal et al., 2007). The resistance by the solution to the movement of 
ions generates friction which, in turn, heats the solution. Dipole rotation involves the 
rearrangement of the molecular dipoles under the influence of the oscillating electric filed. At a 
frequency of 2450 MHz, the dipoles align and realign 4.9 x10
4
 times per second (Letellier et al., 
1999). This rapid movement prevents the solvent molecules from aligning with the electric field. 
The molecules start to vibrate and produce friction which results in heating. Greater than 2450 
MHz, the molecules do not get a chance to start aligning with the electric field, due to an even 
more rapid speed, so no heating occurs (Letellier et al., 1999). At a frequency of less than 2450 
MHz, the molecules are able to align with the electric filed so no heating occurs (Letellier et al., 
1999).  These mechanisms allow for direct localized heating at the surface of the sample and 
result in desorption of the analytes and dissolution in the solvent. 
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The efficiency of solvent heating under microwave irradiation is a function of the dissipation 
factor (tan δ). The dissipation factor is displayed by the following equation: 
tan δ = ε’’/ε’ (Letellier et al., 1999) 
where ε’’ is the dielectric loss factor which describes the efficiency of converting microwave 
energy into heat and ε’ is the dielectric constant which indicates the solvents ability to absorb 
microwave energy. Polar compounds (i.e. methanol and ethanol) absorb microwave energy with 
a greater efficiency due to the presence of a permanent dipole (greater dielectric loss factor) 
(Letellier et al., 1999). Parameters often investigated in MAE include: extraction time, choice of 
solvent, solvent volume, temperature, mass, power and particle size. Table 1 lists the factors that 
affect the extraction efficiency of PSE and MAE. 
Table 1: Factors affecting the extraction efficiency of PSE and MAE 
Parameter PSE MAE 
Extraction Time Solvent, Matrix Solvent, Matrix 
   Particle Size Matrix composition Matrix composition 
   Power N/A Number of samples, Solvent, 
  
Matrix 
   Solvent Dissolution ability, Stability Absorption ability, Stability 
   Solvent Volume Mass Mass 
   Temperature Stability, Solvent Stability, Solvent 
 
1.3.3 Bone Preparation  
Multiple bone preparation techniques have been used to analyze drugs in bone tissue. Table 2 
summarizes some of the preparation methods and the drug isolation techniques used. Passive 
solvent extraction is the most frequently used method to isolate drugs from bone tissue and uses 
a variety of bone preparation techniques. Horak et al. directly compared two different bone 
preparation techniques using passive solvent extraction to detect citalopram and olanzapine. The 
authors incubated full bone and bone silvers in both methanol and water (Horak et al., 2007). 
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Citalopram was the only drug present and it gave the highest signal from bone slivers that were 
extracted in methanol and the lowest signals were achieved from whole bone extracted with 
water (Horak et al., 2007). Ground bone samples have been used for all MAE work completed to 
date by Watterson and collaborators. Acid digestion has been used in two studies to isolate drugs 
from bone matrix (Raikos et al., 2001; Guillot et al., 2007). In both these studies, samples were 
ground prior to digestion. 
Drummer (2008) published a review that highlighted advantages and disadvantages of different 
bone preparation techniques. The most useful bones appear to be long bones as they can be 
sectioned to increase surface area. The author found that soaking annular bone rings in a solvent 
overnight extracts much of the drug contained within the matrix and is not very demanding. To 
increase the extractability, bone could be crushed and soaked in a solvent. However, it may 
introduce health and safety issues for the analyst and is a much more demanding process 
(Drummer, 2008). The use of different preparation methods prevents direct correlation of data so 
results are best represented in a qualitative manner until standardization is achieved. 
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Table 2: Examination of Bone Preparation for Drug Isolation Methods 
Sample Source and Drug Isolation Method Drugs Detected Source 
Bone Preparation 
   
Femoral Bone; PSE: Methanol for 18h Antidepressants, McIntyre et al., 2000 
1-2mm bone rings 
 
Antipsychotics, 
 
  
Benzodiazepines, 
Opiates 
 
    
Iliac crest and vertebra; PSE: Methanol for 16h 
Antidepressants, 
Cocaine McGrath et al., 2009 
Bone slivers 
 
Benzodiazepines, 
Opiates 
 
    Unspecified source; PSE: Methanol for 24h Citalopram Horak et al., 2002 
Whole bone and bone slivers PSE: Water for 24h 
  
    Epiphyseal and diaphyseal PSE: Methanol for 72h Ketamine, Diazepam Watterson et al., 2008 
sections of femora 
 
Amitriptyline, 
Citalopram Watterson et al., 2009 
Central Cavity and Arm 
Bones; 
  
Watterson et al., 2012 
Ground Bone 
  
Watterson et al., 2013 
    Central Cavity and Arm 
Bones; 
MAE: PB6 for 15 and 
30min 
Ketamine, 
Pentobarbital, Desrosiers et al., 2009 
Ground Bone 
 
Diazepam, 
Meperidine Watterson et al., 2011 
    Unspecified source; Acid Digestion: Morphine Guillot et al., 2007 
Ground bone 0.1 M HCl for 12h 6-acetylmorphine 
 
    Thighbone; Acid Digestion: Opiates Raikos et al., 2001 
Ground bone 3 M HNO3 for 24h 
   
1.4 Solid Phase Extraction 
Solid phase extraction (SPE) is a separation technique that involves a selective transfer of a 
material between a solid sorbent and a liquid phase. Separation is achieved through different 
affinities for phases based upon adsorption, size and charge. There are three main mechanisms of 
compound retention on a sorbent: reversed phase, normal phase and ion exchange. In reverse 
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phased SPE, the stationary phase is non-polar (silica or a polymer backbone, modified with alkyl 
or aryl groups) (Arsenault, 2012). Compound retention is a result of hydrophobic (non polar) 
interactions between the C-H bonds in the analyte and C-H bonds on the sorbent. In normal 
phase SPE, the stationary phase is polar (silica modified with alkyl chains containing polar 
functional groups) (Arsenault, 2012). Interactions occurring between polar functional groups of 
the analyte and polar functional groups of the sorbent are responsible for compound retention. 
Polar interactions may include hydrogen bonding, pi-pi interactions, and dipole-dipole 
interactions. 
Ion exchange SPE is broken down into two groups: anion exchange and cation exchange. Anion 
exchange stationary phases are composed of either quaternary amine functional groups (strong 
anion) or secondary amines (weak anion) bonded to a silician backbone (Arsenault, 2012).  
Cation exchange stationary phases are composed of either sulfonic acid groups (strong cation) or 
carboxylic acid functionalities (weak cation) bonded to a silician backbone (Arsenault, 2012). 
Compounds are retained on the basis of the attraction between the charged functional group on 
the analyte and that on the sorbent. To ensure that attraction occurs, the pH of the aqueous 
solution must be sufficient to charge both functionalities within the analyte and on the sorbent. 
Mixed mode SPE sorbents make use of two mechanisms to achieve compound isolation; 
reversed phased (alkyl functional groups) and ion exchange (amine or acid functionalities) 
(Arsenault, 2012). Compounds are initially retained to the sorbent by hydrophobic interactions. 
Basic samples are acidified which charges the amino group and allows the sample to bind to the 
sorbent through ionic interactions.  
SPE can be divided into five major steps: conditioning, equilibration, loading, washing and 
elution. Conditioning is performed, using a strong organic solvent (e.g. methanol), to wet the 
porous surface (activation of the stationary phase) and create a pathway between the sorbent and 
the sample (Arsenault, 2012). Equilibration, using water and the sample solvent, replaces the 
methanol in the pores with sample solvent to allow compounds of interest to interact with the 
sorbent (Arsenault, 2012). Samples, diluted in the same aqueous solvent as the equilibration step, 
are loaded onto the sorbent and allowed to flow by gravity (Arsenault, 2012). Washing, using a 
series of solvents, is performed to remove matrix constituents with less retention to the sorbent 
and may interfere with the analysis (Arsenault, 2012). Within the washing step, sorbents are 
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dried using a vacuum which removes any residual solvent and water within the sample. Elution 
is performed using a solvent that is able to break interactions between the analyte and the sorbent 
(Arsenault, 2012). In the case of basic compounds, a strong organic solvent with a small amount 
of ammonia is used to neutralize a charged amine group and allow analyte desorption into the 
solvent. 
1.5  Gas Chromatography Mass Spectrometry 
Chromatography began in the 1900s with Mikhail Tvest who examined the application of liquid 
samples to homemade columns of various adsorbents (Sparkman et al., 2011). In 1950, Martin 
and James developed gas chromatography (GC) after reading a report about partitioning 
chromatography, published in 1941 (cited in Sparkman et al., 2011). Mass Spectrometry (MS) 
began in the late 1800s with Thompson and Wien and was dominated by analyzing nuclides that 
made up known elements until the 20
th
 century when petroleum products and organic compounds 
became the focus of MS (cited in Sparkman et al., 2011). The first reports of interfacing these 
two techniques were illustrated in 1956 using a GC and time of flight (TOF)-MS and in 1957 
using a GC and a magnetic sector MS (Sparkman et al., 2011). At this time, data were manually 
entered into a computer. In 1965, the first minicomputer was developed by Digital Equipment 
Corporation to acquire and process GC-MS data (Sparkman et al., 2011). By the 1900s, faster 
data systems were developed and were being routinely used (Sparkman et al., 2011). Today’s 
instrumentation has seen significant improvements in areas such as the injector, columns, 
ionization sources and flow and pressure control and the compact size allow for bench-top 
applications. These have all led to user-friendly instrumentation and better sensitivity. 
Chromatography is an analytical technique that separates constituents in a sample based upon 
their interaction between the mobile and stationary phases. Separation is a result of different 
distribution coefficient for various constituents.  The distribution coefficient is a function of the 
time spent in the stationary phase and time spent in the mobile phase (Skoog et al., 2010). A 
constituent that spends more time in the stationary phase will be retained longer. The opposite is 
true of a constituent that spends less time in the stationary phase. The efficiency of separation is 
based upon two factors: differences in elution time (function of distribution coefficient) and how 
broad the peaks are (diffusion) (Skoog et al., 2010). The van Deemter equation illustrates how 
multiple paths (A), longitudinal diffusion (B) and the mass transfer between the mobile phase 
9 
 
 
and stationary phase (C) will impact the efficiency of a separation (H; resolution). The equation 
is shown below: 
    
 
 
    (Skoog et al., 2010) 
where μ is the linear velocity (Skoog et al., 2010). The multiple paths term refers to how many 
possible paths the molecule can take through the column to reach the detector. In open tubular 
columns, this term goes to zero. Longitudinal diffusion refers to the extent of band broadening in 
the sample. The mass transfer term refers to the equilibrium of the samples between the mobile 
and stationary phases. For a given sample, if the travel time through the column is too long, this 
results in a slower interaction between the mobile and stationary phases and the peaks will 
broaden (short and robust) which will decrease resolution. 
Plate height (H) is a measure of column efficiency. As particle size decreases, efficiency 
(number and height of theoretical plates) increases. The length of the column (L) will also affect 
efficiency as shown in the equation below: 
  
 
 
 (Skoog et al., 2010) 
where N represents the number of theoretical plates. As the length of a column increases, there 
are more stationary phase particles which results in more theoretical plates and a decreases plate 
height. The number of theoretical plates is inversely proportional to the peak width (Skoog et al., 
2010). Short peak widths result in tall, narrower bands, minimizing diffusion. Narrower peaks 
provide a greater peak capacity per unit time; increasing efficiency (Skoog et al., 2010). 
In GC-MS, a liquid sample is loaded into an injection port, where it becomes vaporized, and is 
transported through the column, containing the stationary phase, by a gaseous mobile phase 
(carrier gas) to the detector (mass spectrometer). Helium is commonly used as the carrier due as 
opposed to hydrogen and nitrogen, to its non-explosive nature compared to hydrogen and solutes 
are better able to rapidly diffuse through it compared to nitrogen (Skoog et al., 2010). Open 
tubular columns made of fused silica are generally used as they offer higher resolution, and 
shorter analysis times compared to packed columns (Skoog et al., 2010). There are many factors 
that can affect the efficiency of a column which include stationary phase thickness, column 
diameter and column length. The majority of GC analyses involve temperature programming. 
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The temperature of the column is raised during the separation to terminate constituent 
interactions which increase the analyte vapour pressure, decrease the retention time of late 
eluting compounds and create narrower peak profiles (Skoog et al., 2010). This technique is 
more suited to volatile, non-thermally labile compounds which may limit its application for 
certain types of compounds. However, one way to make this technique more applicable would be 
derivatization. Derivatization is the chemical modification of a compound to improve its 
detectability using GC by way of increasing volatility and stability. These reactions fall into 
three categories: alkylation - esterification, silylation and acylation. Alkylation involves the 
replacement of active hydrogen by an aliphatic or aromatic group resulting in less polar 
compounds (Orata, 2012). In silylation, active hydrogen is replaced by a silyl group reducing the 
polarity of the compound (Orata, 2012). Acylation involves the replacement of active hydrogen 
with acyl group rendering the compound less polar (Orata, 2012). 
After separation, compounds are passed through a transfer line and enter the mass spectrometer. 
Compounds enter the ionization chamber and undergo ionization by electron impact ionization 
(EI). EI is the most commonly used form of ionization and involves the interaction of 
compounds with a high energy electron beam, producing a positively charged molecular ion 
(M+). The high energy electron beam is produced by applying a set voltage, 70 eV, to a heated 
filament which forces the electrons to move from the surface of the filament to ground (Levine, 
2010). These high energy electrons cause destabilization of the compounds which results in 
rearrangement and bond breakage, ultimately fragmenting the compound (Levine, 2010). EI 
produces unique, reproducible spectra that can be compared to standard libraries to aid in 
identification. Following ionization, ions are passed into the mass analyzer. The single 
quadrupole is a commonly used mass analyzer that is composed of four metal rods that are 
arranged in parallel sets to which a constant and radio-frequency voltage are applied (Levine, 
2010). Adjustment of the radio-frequency voltage will permit ions, with a defined set of mass-to-
charge ratios, to pass through the rods and enter the detector (Levine, 2010). Ions without the 
defined mass-to-charge ratios will deflect into the rods (Levine, 2010). Target analyses operate 
single quadrupoles in selected ion monitoring mode (SIM) due to the increased sensitivity and 
selectivity. This involves monitoring specific ions (usually includes one quantifier and two 
qualifiers) for each compound of interest (Levine, 2010). Monitored ions travel to the detector 
which measures and converts them to intensity, producing a mass spectrum.   
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1.6 Drug Detection in Human Bone and Bone Marrow 
The first study to use skeletal tissues as a biological specimen was conducted by Noguchi et al. 
in 1978. The authors used bone marrow from the odontoid process of the top eight vertebrae. 
Amitriptyline (0.07 mg) was recovered from 51.8 g bone marrow sampled (Noguchi et al., 
1978). From this study, the police were able to search local pharmacies and determine that the 
deceased had been given a prescription for amitriptyline (Noguchi et al., 1978). Since this was 
the first discovery of drugs in skeletal tissues, the authors could not make any definitive 
conclusions but this illustrated a possibility for further use of skeletal tissues. Seven years later, 
sternum samples, along with cadaver organs and blood, were used to detect barbiturates and 
glutethimide (Benko, 1985). Out of the ten cases examined, amobarbital (n=7), glutethimide 
(n=5), phenobarbital (n=2) and butobarbital (n=1) were found (Benko, 1985).  Some other earlier 
studies involved the detection of methamphetamine and amphetamine thigh bone marrow 
following five years of decomposition in 1986 (Okamoto et al., 1986) and triazolam in bone 
marrow following four years of decomposition in 1997, which was used to confirm suspected 
murders statements (Ludo et al., 1997). 
The most extensive and significant study examining the use of skeletal tissues in humans was 
conducted by McIntyre and colleagues in 2000. The authors examined rings of mid-femoral bone 
of chronic prescription drug users along with routine blood samples collected after autopsy. 
Decomposed bodies were excluded from analysis. Drugs were detected in bone in 25 out of the 
29 blood positive cases (McIntyre et al., 2000). Diazepam (n=16) and nordiazepam (n=13) were 
the most commonly detected drugs (McIntyre et al., 2000). Eleven cases involved 
antidepressants with the most commonly detected being amitriptyline, nortriptyline, doxepin and 
dothiepin. Antipsychotic drugs detected include thioridazine (n=4), chlorpromazine (n=1) and 
clozapine (n=1). Other drugs detected include: propoxyphene, carbamazepine, methadone, 
codeine, oxycodone and chlormethiazole. McIntyre and colleagues also examined bone marrow 
from blank cases (people not using the drugs) and chronic users of prescription drugs. The first 
study involving bone marrow aimed at determining whether or not drugs could be detected in 
femoral bone marrow (McIntyre et al., 2000). Some of the drugs detected include: amitriptyline 
(n=2), nortriptyline (n=2), doxepin (n=4), nordoxepin (n=2), sertraline (n=1), moclobemide 
(n=1) and chlorpromazine (n=1). Similar to bone, benzodiazepines were detected in the most 
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cases; diazepam (n=5), nordiazepam (n=6), temazepam (n=3) and oxazepam (n=3). Other drugs 
included: propoxyphene, methadone and oxycodone. 
The second study involving bone marrow aimed to determine a correlation between human blood 
drug concentrations and lumbar bone marrow.  Drugs detected in lumbar bone marrow include 
mianserin, nordoxepin, doxepin, sertraline, moclobemide, thiordazine, mesoridazine and 
olanzapine. Similar to the femoral bone marrow study, benzodiazepines were detected more 
frequently than other drug classes. In all positive bone marrow cases, the bone marrow 
concentrations were greater than the blood concentrations (McIntyre et al., 2000). Blood and 
bone marrow concentrations for benzodiazepines showed a positive correlation indicating that 
bone marrow concentrations may be representative of post-mortem drug concentrations in blood.  
The varying amount of positive cases in each bone marrow study may be a result of the type of 
bone marrow used. Femoral bone marrow is mainly yellow whereas lumbar bone marrow is 
mainly red and both have different affinities for drugs. This study provided positive evidence 
that multiple classes of drugs can be detected in skeletal tissues and these may serve as useful 
alternatives to standard specimens. 
Opiate concentrations were determined in fresh bone, bone marrow and buried bone of a 
deceased heroin addict in 2001 (Raikos et al., 2001). The fresh thighbone had a morphine 
concentration of 340 ng/g while the buried bone gave a morphine concentration of 155 ng/g 
which represented a 54.4% loss in morphine concentration (Raikos et al., 2001). One other 
interesting finding was that the bone weighed 17% less after burial (Raikos et al., 2001). This 
was the first study to directly compare drug concentrations in fresh and decomposed bone tissue 
and it indicates that the post-mortem environment has an influence on the observed drug 
concentrations. A second, larger scale, study was conducted by McGrath and Jenkins in 2009 
that looked at drug detection in bone where toxicological analysis yielded a positive blood result 
(McGrath et al., 2009). The authors used individuals ranging from newborn to 81 and analyzed 
the iliac crest in adults and vertebra in infants (McGrath et al., 2009). Decomposed remains were 
excluded from analysis. Amitriptyline, citalopram, meperidine, cocaine, codeine, and 
benzodiazepines were among the most frequently detected drugs in both blood and bone. The 
authors noted that drugs were less likely to be detected in bone however when present, the bone 
usually gave higher concentrations (McGrath et al., 2009). Also, the authors saw no correlation 
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between blood concentrations and bone concentrations (McGrath et al., 2009). This study 
reiterated the potential of skeletal tissues to determine drug exposure. 
1.7 Drug Detection in Animal Bone and Bone Marrow 
Winek and colleagues (1982) completed a large amount of research on fresh skeletal tissues 
using rabbits as the model specimen. Rabbits were dosed intraperitoneally with a variety of drugs 
to see if there was a positive correlation between bone marrow and plasma concentrations. The 
lipid content of bone marrow samples was taken into account in some studies to examine if it had 
any effect on the observed blood to bone marrow ratios. The blood to bone marrow ratios were 
improved when corrected for lipid content for both methanol (Winek et al., 1982) and 
isopropanol (Winek et al., 1982). In the study involving isopropanol, acetone was a produced 
during the metabolism and its blood to bone marrow ratios were also calculated. Acetone was 
affected by storage conditions and delays between death and analysis hindering its correlation 
ability (Winek et al., 1982). All other drugs investigated showed strong, linear relationships 
between blood and bone marrow concentrations, except flurazepam. Overall the data implies that 
bone marrow concentrations can be used to predict blood concentrations. Table 3 shows the 
blood to bone marrow ratios and the correlation data for drugs examined by Winek and 
colleagues. 
Gorczynski et al. (2001) examined midazolam in bone tissue and bone marrow following acute 
and chronic administration in mice. Midazolam was detected in both exposure patterns for the 
bone marrow but only in the chronic exposure for the bone. An important consideration in this 
study is that the authors indicated they had not removed all soft tissue from the bone samples so 
they could not exclude the possibility that the positive concentrations may have come from the 
soft tissues. This study also looked to examine the effect of freezing samples as well as burying 
samples in sterile and non-sterile soil, on amount of drug observed in chronic dosing. Bone 
marrow concentrations of midazolam were the same for both frozen samples and samples that 
were buried in sterile soil, but were not detectable in samples buried in non-sterile soil 
(Gorczynski et al., 2001). Midazolam was detectable in all situations for the bone samples with 
the highest concentration in the frozen samples and lowest in the non-sterile soil (Gorczynski et 
al., 2001). These results confirm that midazolam is in the bone itself as there is endogenous 
tissue present (Gorczynski et al., 2001). This study further supports the notion that 
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Table 3: Summary of Winek Studies illustrating the ratio between blood and bone marrow 
concentrations 
Drug Examined Blood to Marrow 
Ratio 
Correlation Results Reference 
Methanol Observed: 2.57 ± 0.61 Positive correlation Winek et al., 1982 
 
Corrected: 1.60 ± 0.34 
  
    Isopropanol Observed: 2.26 ± 0.38 Positive correlation Winek et al., 1982 
 
Corrected: 1.45 ± 0.17 
  
    Acetone Observed: 2.81 ± 0.71 Positive correlation Winek et al., 1982 
 
Corrected: 1.82 ± 0.47 
  
    Flurazepam 0.029 ± 0.012 Positive correlation Winek et al., 1982 
  
R
2
 = 0.878 
 
    
Pentobarbital 1.06 ± 0.05 
Strong, positive 
correlation Winek et al., 1985 
  
R
2
 = 0.950 
 
    
Desipramine 37.204 ± 4.461 
Strong, positive 
correlation Winek et al., 1990 
  
R
2
 = 0.919 
 
    
Nortriptyline 28.92 ± 3.91 
Strong, positive 
correlation Winek et al., 1993 
  
R
2
 = 0.956 
   
post-mortem environment will influence observed drug concentrations. Guillot and collaborators 
examined morphine and 6-acetylmorphine (6-AM) concentrations in mice bone marrow and 
bone following acute and chronic administration of heroin (diacetylmorphine). Morphine and 6-
AM were detected in blood, bone marrow and bone following the acute exposure, with morphine 
having higher concentrations than 6-AM, but not in the chronic case. There was no correlation 
between blood, bone marrow and bone the authors suggest this is a result of the given lethal dose 
not attaining proper equilibrium (Guillot et al., 2007). The authors also examined bones that had 
been stored on soil in a jar for two months. 6-AM was detectable in the bone marrow but had a 
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71% loss, whereas morphine underwent a 100% loss (Guillot et al., 2007). After two months of 
storage, no drugs were detectable in the bone samples (Guillot et al., 2007). This study showed 
significant variation in the concentrations observed. This was due, in part, to the mice not being 
sacrificed at the same time; all were sacrificed 3 to 8 minutes post-dose. 
The most recent work examining drugs in skeletal tissues was conducted by Watterson and 
colleagues (2008). Some of the first reported work involved the detection of drugs in rat bone 
and bone marrow using ELISA. The ELISA data were presented in terms of a percent decrease 
in absorbance (%DA) to account for cross-reacting endogenous compounds and to make the 
ELISA data increase with increasing drug concentration (Watterson et al., 2008). Rat bone and 
bone marrow were assayed for ketamine following different periods of delay between drug 
exposure and death, using an acute dose. The authors noted that as the dose-death interval 
increased, the %DA decreased and there was no significant difference between the %DA for the 
15 and 30 minute dose-death intervals (Watterson et al., 2008). The authors also examined the 
%DA values in different sections within a bone and found that epiphyseal sections (distal ends) 
had a greater ketamine %DA than the diaphyseal sections (midsection) of the femurs. Also, 
epiphyseal sections showed a difference in response for the groups sacrificed after 15 and 30 
minutes but no difference was displayed in diaphyseal sections (Watterson et al., 2008). A 
similar study was conducted using diazepam. The dose-death intervals varied significantly in the 
bone marrow samples and the epiphyseal sections but not in the diaphyseal sections (Watterson 
et al., 2008). 
Watterson and colleagues also completed a study involving examining the distribution of drugs 
in decomposed skeletal tissues. Amitriptyline, pentobarbital and diazepam were examined in 
twelve different bones types of a decomposed pig.  Drug levels are reported as mass normalized 
response ratios (RR/m). The largest RR/m values were observed in the rib for all bone types 
examined (Watterson et al., 2010). Large RR/m values were also found in the vertebra, pelvi and 
femora (Watterson et al., 2010). ANOVA analysis was performed and showed bone type to be a 
main effect with respect to the drug levels observed. The authors also noted that examination of 
ratio of levels of diazepam and nordiazepam showed less variability than individual drug RR/m 
values (Watterson et al., 2010). As a result, the authors completed a similar study, using the same 
pig, to determine if the trend of lower site-dependent variability in the ratio of parent drug and 
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metabolite extended to amitriptyline and citalopram using thirteen different bone types. Once 
again, ANOVA showed bone type to be a main effect for the drug levels observed (Desrosiers et 
al., 2012). It was found that the mean levels (RR/m) of individual drugs varied by a factor of 45 
and 33 for amitriptyline and nortriptyline across all bone types examined while citalopram and 
desmethylcitalopram varied by a factor of 166 and 95 respectively (Desrosiers et al., 2012).The 
mean levels (RR/m) of the ratio of parent drug and metabolite showed much less variability, 
varying only 1 to 8-fold across all bone types examined (Desrosiers et al., 2012). The relative 
stability of the ratio of levels of parent drug and metabolite compared to the levels of the 
individual drugs may provide valuable insight into accessing the circumstances of drug exposure 
(Desrosiers et al., 2012).  
Their most recent work involves discriminating different patterns of drug exposure by way of 
levels of individual drugs as well as the ratio of levels of parent drug and metabolite.  Ketamine 
and norketamine were examined in multiple bone tissues following acute and repeated exposures 
(Watterson et al., 2012). This study found that ketamine drug levels were able to discriminate 
patterns of drug exposure for all bone types while norketamine and the ratio of levels of 
ketamine and norketamine were able to discriminate patterns of drug exposure for the majority of 
bone types examined (Watterson et al., 2012). Pooled levels were also able to discriminate drug 
exposure patterns. Amitriptyline, citalopram and metabolites were also examined in a similar 
study (Watterson et al., 2013). Individual drug levels (RR/m) of AMI, CIT and their metabolites 
did not differ significantly between the two exposure types for individual bone types, in most 
cases, or for the pooled comparison of all bone types, in all cases (Watterson et al., 2013). 
Conversely, the ratio of levels of metabolite and parent drug (RRmetabolite/RRparent) differed 
significantly within each bone type between acute and repeated exposures in most cases. In the 
analysis of pooled bone data, levels of RRmetabolite/RRparent differed significantly between 
exposure patterns in all cases. For analysis of citalopram and metabolites, values of 
RRDDMCIT/RRDMCIT showed the greatest discrimination between exposure patterns (Watterson et 
al., 2013). This result indicates that is important to consider more than just the primary 
metabolite and its relationship to the parent drug (Watterson et al., 2013). These studies indicate 
that when using skeletal tissues, the relationship between the parent drug and metabolite may 
provide more insight into the drug exposure pattern. 
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1.8 Pharmacology of Ketamine 
Ketamine (KET), (RS)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone, is a basic drug with 
a pKa of 7.5 and an analog of phencyclidine (PCP) (Levine, 2010). Usually found as a 
hydrochloride salt under the generic name Ketalar, it is used as an anesthetic and/or analgesic in 
human and veterinary medicine (Katzung et al., 2009). KET has become an abused drug due to 
the production of an anesthetic state termed dissociative anaesthesia. This is characterized by 
catatonia, amnesia and analgesia with or without the loss of consciousness (Kohrs et al., 1998). 
KET acts as an antagonist on N-methyl-D-aspartate (NMDA) receptors and inhibits glutamate 
activation of the channel in a non-competitive manner (Kohrs et al., 1998). The blockage is time-
, concentration- and frequency-dependent (Korhs et al, 1998). This is considered to be the 
primary site of KET’s anesthetic action (Korhs et al., 1998). KET displays agonist activity on the 
κ-opioid receptor, which induce psycho-mimetic reactions typical in KET anesthesia and has 
some antagonist activity on the μ-receptor (Korhs et al., 1998). KET has also been shown to 
interact with other receptors including muscarinic acetylcholine receptors, sodium channels and 
L-type calcium channels. A summary of the effects produced by each receptor type are found in 
Table 4. Providing an individual with a dose of diazepam, midazolam or propofol prior to KET 
will reduce some of these adverse effects (Katzung et al, 2009). KET in conjunction with other 
intravenous and inhaled anesthetics has been used as an alternative to opioid analgesics for 
ventilator depression (Katzung et al., 2009). 
KET is a chiral molecule that is composed of two optical isomers: 50% R (-) and 50% S (+) 
Ketamine (Levine, 2010).The enantiomers have a varying affinity for different receptors. S (+) 
KET has a fourfold greater affinity for the NMDA receptor and a twofold greater affinity for the 
muscarinic receptors (Korhs et al., 1998). KET is most commonly administered intravenously 
but has also been administered subcutaneously, intramuscularly, intranasal or orally (Levine, 
2010). It has a volume of distribution of 3-4 L/kg and a half-life of 3-4 hours in humans (Levine, 
2010). The half-life of KET in rats has been shown to range from 0.7 to 2.5 hours (Williams et 
al., 2004).  KET undergoes an N-demethylation (CYP P450 enzymes) to form its major 
metabolite norketamine (NKET) (Levine, 2010). NKET is thought to have one third the 
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Table 4: Receptor Mediated Clinical Effects of Ketamine 
Receptor Clinical Effects References 
N-methyl-D-aspartate Hallucinations, nausea, 
vomiting, blurred vision, 
increased or decreased 
respiration, heart rate and/or 
blood pressure 
(Levine, 2010) 
   
Opioid (μ and κ) Seizures, paranoia, delirium, 
psychosis, dizziness, anxiety, 
palpitations 
(Korhs et al., 1998) 
   
Muscarinic Acetylcholine Memory loss, consciousness, 
mydriasis, amnesia, bronchial 
and mucus secretion 
(Durieux, 1995) 
   
Sodium Channels Sympathetic, sensory and motor 
blockages 
(Durrani et al., 1989) 
   
L-type Calcium Channels Vasodilation, bronchodilation, (Sinner et al., 2008) 
  
anesthetic activity of KET (White et al., 1982). NKET becomes dehydrogenated to form 
dehydronorketamine (DHNK) (Levine, 2010). KET and its metabolites may also undergo 
hydroxylation and conjugation (Levine, 2010). The majority of KET and its metabolites are 
excreted in the urine with 4% being unchanged drug and around 80% being conjugates (White et 
al., 1982). Fecal excretions account for less than less than 5% of a dose (White et al., 1982). 
Analgesia begins at plasma concentrations of 100 ng/mL (Sinner et al., 2008). Anesthetic blood 
concentrations range from 2000 to 3000 ng/mL and individuals begin to awake between 500 and 
1000 ng/mL (Sinner et al., 2008). Blood concentrations in an overdose were observed to be 
greater than 3000 ng/mL (Levine, 2010). KET and its metabolites have been analyzed by 
multiple methods. The majority of the methods used for analysis are gas chromatography with 
electron impact ionization mass spectrometry. Table 5 lists some of the methods used in the 
analysis of ketamine and its metabolites. Hijazi et al. examined the stability of ketamine, 
norketamine and dehydronorketamine in human serum and plasma. The human serum stability  
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Figure 1: Structures of (A) Ketamine, (B) Norketamine and (C) Dehydronorketamine.  
studies were conducted at -20˚C for 6 months and 4˚C for 2 days. The authors saw no significant 
difference in drug levels following storage in either condition (Hijazi et al., 2001). Human 
plasma stability studies were also conducted at temperatures of 4˚C and 20 ˚C for 2 hours. KET 
and NKET plasma concentrations were stable for 2 hours at both temperatures and DHNK 
plasma concentration was stable for 2 hours at 20˚C (Hijaki et al., 2001). At 4 ˚C, DHNK had a 
68% loss in plasma concentration after 30min of storage (Hijaki et al., 2001). The authors 
believe this is a result of permeation of DHNK into the blood cells (Hijaki et al., 2001). The 
authors concluded that plasma at room temperature should be analyzed immediately to avoid any 
decrease in DHNK concentrations.  
 
 
 
 
A 
B C 
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Table 5: Methods used to detect Ketamine and its Metabolites in Biological Specimens 
Analytical Method and  Sample Preparation LoD Reference 
Sample Type       
GC-FID; plasma Liquid liquid 
extraction  
KET: 500 ng/mL (Hodshon et al., 
1972) 
    
GC-NPD; urine Hexane extraction KET: 5.0 ng/mL (Lin et al., 2005) 
  NKET: 5.6 ng/mL  
    
GC-EI-MS; fingernails Hydrolysis, ethyl 
acetate 
KET: 0.094 ng/mg (Kim et al., 2010) 
 extraction NKET: 0.094 ng/mg  
    
GC-EI-MS; hair Digestion, liquid liquid  KET : 0.05 ng/mg (Xiang et al., 2006) 
 extraction NKET : 0.05 ng/mg  
    
GC-EI-MS; urine Ethyl acetate 
extraction, 
derivatization 
KET: 2 ng/mL (Lin et al., 2006) 
 NKET: 1 ng/mL  
 DHNK: 6 ng/mL  
    
GC-EI-MS; urine Solid phase extraction, KET: 0.5 ng/mL (Huang et al., 2005) 
 derivatization NKET: 0.5 ng/mL  
  DHNK: 0.5 ng/mL  
    
GC-PICI-MS; urine Solid phase extraction  KET: 25 ng/mL (Kim et al., 2008) 
  NKET: 25 ng/mL  
    
HPLC-PDA; plasma Liquid liquid 
extraction  
KET: 5 ng/mL (Bolze et al., 1998) 
  NKET: 5 ng/mL  
  DHNK: 10 ng/mL  
    
LC-ESI-MS; urine Solid phase extraction KET: 0.03 ng/mL (Parkin et al., 2008) 
  NKET: 0.05 ng/mL  
    
LC-APCI-MS; plasma Dilution with water KET: 0.95 ng/mL (Chen et al., 2007) 
  NKET: 0.48 ng/mL  
    DHNK: 0.33 ng/mL   
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Chapter 2 
2 Microwave Assisted Extraction of Ketamine and its Metabolites in Skeletal 
Tissues 
 
The use of Microwave Assisted Extraction (MAE) to extract ketamine and its metabolites from 
decomposed bone tissue is described. Wistar rats received 75 mg/kg (i.p.) ketamine (n=12) or 
remained drug-free (controls, n=4). Following euthanasia, rats were allowed to decompose to 
skeleton outdoors. Bones (vertebrae, rib, pelvis, femora, tibiae¸ humeri and scapulae) were 
collected and pooled. Analyte stability to MAE in methanol or acetone: hexane mixture (1:1, v/v) 
in a closed vessel microwave system was assessed, and acetone:hexane was chosen as the MAE 
solvent. Bone samples underwent MAE, and extracts were assayed using microplate solid phase 
extraction (MPSPE) in a mixed-mode configuration and gas chromatography-mass spectrometry.  
Drug levels, expressed as mass normalized response ratios, were used to characterize extraction 
time and the effect of MAE solvent volume on the extraction time and relative recovery for each 
analyte and subsequent comparison to assays of extracts obtained through passive solvent 
extraction (PSE). Extraction time varied slightly with solvent volume, while relative analyte 
recovery did not differ significantly. Recovery was at least 90% of maximal value within the first 
5 min for all samples examined and maximum recovery occurred within 20 minutes for MAE 
and 3 hours for PSE. MAE in combination with MPSPE offers a substantial improvement in 
analytical throughput for toxicological analysis of skeletal remains. 
2.1 Introduction 
Over the last fifteen years, there has been an increasing amount of research involving the 
toxicological analysis of skeletal tissues (McIntyre et al., 2000, Gorczynski et al., 2001, Horak et 
al., 2005, McGrath et al., 2009, Desrosiers et al., 2012, Watterson et al, 2012). The majority such 
analyses reported have used passive methanolic extraction to isolate the drugs from bone 
samples (Horak et al., 2005, McGrath et al., 2009, Watterson et al, 2009, 2010). These methods 
reported very time consuming extractions, utilising 12-72 hours of incubation time (McIntyre et 
al., 2000, Gorczynski et al., 2001, Horak et al., 2005, McGrath et al., 2009 Desrosiers et al., 
2012, Watterson et al, 2012). Given the wide variability in detected drug and metabolite levels 
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across different bone types (Watterson et al., 2010, 2011, Desrosiers et al., 2012, Watterson et 
al., 2012), new advances in this area will require significant increases in the number of samples 
analysed, which, in turn, underscores the need for a method with a higher analytical throughput. 
One such approach would be the use of Microwave-Assisted Extraction (MAE). MAE has been 
used to detect compounds in environmental samples (soil and sediment) including polycyclic 
aromatic hydrocarbons and polychlorinated biphenyls (Bartolomé et al., 2005), endocrine 
disrupting chemicals (Liu et al., 2004) and triazines (Xiong et al., 1999). MAE has also been 
used to detect drugs in biological matrices including cocaine and opiates (Fernandéz et al., 2007, 
2009), tricyclic antidepressants (Wózniakiewicz et al., 2008) and anti-inflammatory drugs 
(Fernandéz et al., 2013). 
In MAE, microwave radiation is absorbed by the solvent and/or sample, which leads to sample 
heating by two mechanisms: ionic conduction and/or dipole rotation. Ionic conduction is a result 
of resistive heating of the solution as ions migrate under a changing electric field. Dipole rotation 
involves rearrangement of the molecular dipoles under the influence of the oscillating electric 
field. Molecular dipoles are unable to realign with the oscillating field, and undergo vibrations 
that create frictional heating. This process allows the heating to be applied in a focused manner 
towards the matrix of interest which results in desorption of analytes and dissolution in the 
solvent (Letellier et al., 1999, Mandel et al., 2007).The ability of a material to absorb 
microwaves is a function of its dielectric loss factor, which is related to the efficiency of 
converting microwave energy into heat and is a function of the permittivity of the material. Polar 
solvents, such as methanol and ethanol, have higher dielectric constants than non-polar solvents 
so they will absorb microwave energy with a greater efficiency. In MAE, the microwave 
irradiation directly heats the absorbing material, with minimal reliance on conductive and 
convective heat transfer. Factors that have been shown to influence microwave assisted 
extraction include solvent polarity, volume, time, moisture, power and temperature (Letellier et 
al., 1999, Mandel et al., 2007). 
This laboratory has conducted various studies of the disposition of ketamine (KET) and 
its major metabolite norketamine (NKET) in skeletal tissues (Watterson et al., 2008, 2011, 
2012). However, none of this work has examined dehydronorketamine (DHNK), a secondary 
metabolite of ketamine. The overall purpose of this work was to improve our sample preparation 
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protocols for analysis of ketamine and its metabolites, including validation of the analysis of 
DHNK as well as KET and NKET, in bone tissue by moving to a microwell plate-based solid-
phase extraction assay, with incorporation of MAE as the means to isolate the analytes from 
solid bone. Improved throughput in sample preparation is critical to expanding the catalogue of 
data describing drug and metabolite disposition in skeletal tissues after various patterns of 
exposure, which is vital to improving our ability to derive toxicological information from these 
measurements. This study reports the effect of solvent choice, solvent volume and irradiation 
time for the recovery of KET and its metabolites (NKET and DHNK). The drugs of interest were 
extracted from pooled, ground bone tissue from acutely exposed animals that underwent outdoor 
decomposition for 3 weeks. Tissue extracts were analyzed by gas chromatography mass 
spectrometry (GC-MS). 
2.2 Experimental  
2.2.1 Chemicals 
Methanol used in the drug extraction was HPLC grade and obtained from EMD Chemicals 
(Gibbstown, NJ). KET and NKET (Cerillant, Round Rock, Texas) were obtained as 1.0 mg/mL 
methanolic solutions and diluted as required. KET-d4 and NKET-d4 (Cerillant, Round Rock, 
Texas) were obtained as 100 µg/mL methanolic solutions and diluted as required.  DHNK 
(Cerillant, Round Rock, Texas) was obtained as a 100 µg/mL acetonitrile solution and diluted as 
required. Acetonitrile used was reagent grade and obtained from J.T. Baker (Center Valley, PA). 
Phosphate buffer (PB6) was prepared by dissolving 13.8 g of monobasic sodium phosphate in 1 
litre of water. This solution was adjusted to pH 6.0 using 4M sodium hydroxide. All other 
chemicals were reagent grade and obtained from EMD chemicals. 
2.2.2  Animals and Drug Administration 
Male Wistar rats (n=12) acutely exposed to ketamine were donated by Dr. T.C. Tai of the 
Northern Ontario School of Medicine. The animals used were housed at the Laurentian 
University Animal Care Facility. Upon arrival at the facility, the animals were given 7 days to 
acclimatize to their conditions. Adult male Wistar rats (Charles River Laboratories, St. Constant, 
QC, Canada) were housed in groups of three with Harlan Teklad ¼” bedding (Indianapolis, IN) 
on a 12 h light ⁄ dark cycle at a room temperature of ca. 20oC. They were supplied with free 
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choice water and Harlan Teklad Laboratory Diet 8640. The procedures used in this experiment 
were approved by the Laurentian University Animal Care Committee. The rats were given 75 
mg/kg KET (i.p.) and euthanized by CO2 asphyxiation within 20 minutes of drug administration. 
This dose was chosen as it is an anesthetic dose in rats. The rats were placed in cages outdoors at 
a rural Ontario site and allowed to decompose for 3 weeks during late spring (May-June) with 
full exposure to weather features (sunlight, precipitation etc.). Drug free rats (n=4) were placed 
outdoors and exposed to the same conditions and serve as negative controls. Bones collected for 
analysis include vertebrae, ribs, pelvis, tibiae, femora, scapulae, radii, ulnae and humeri. 
2.2.3  Bone Preparation  
All bone types collected for rats undergoing the same drug exposure were pooled for analysis 
(i.e., drug positive vs. drug free). All bones were washed sequentially with phosphate buffer 
(PB6: 0.1M, pH 6.0), methanol and acetone to remove any loosely bound soil and other 
contaminants. Bones were left out to air-dry for 48 hours. Bones were first ground using a 
Micro-Mill grinding mill (Bel-Air Products, Pequannock, NJ) for 2min followed by 
pulverization to a fine powder using a Ball Mill (SPEX Sample Prep., Metuchen, NJ) for 1min.  
2.2.4 Solid-Phase Extraction and Gas Chromatography Mass Spectrometry 
Samples of drug-free decomposed bone (100g) were sonicated in 500 mL PB6, to prepare the 
drug free bone tissue extract (BTE) used in method validation. All calibrant samples were 
prepared in 1 mL BTE at concentrations varying from 0 to 2000 ng/mL in replicate analysis 
(n=3). Internal standards [200ng KET-d4 and 200ng NKET-d4] were added to each sample along 
with 100µL glacial acetic acid and 3 mL acetonitrile: methanol (1:1 v/v), followed by storage at -
20˚C for 12h to precipitate proteins and lipids. The samples were centrifuged (1100×g) for 10 
min and the supernatant was collected and evaporated to 1mL under a gentle stream of air 
(70˚C). The samples were diluted to 4 mL with PB6 (0.1M, pH 6.0) and acidified with 100µL 
glacial acetic acid.  
Solid phase extraction was performed using CleanScreen XCEL 1 48 Well Plates (130 mg, 
United Chemical Technologies, Bristol, PA). Wells were first conditioned with 3mL methanol, 3 
mL distilled water and 3 mL PB6. Samples were loaded into the wells and allowed to flow by 
gravity. The wells were washed with 3 mL PB6 (0.1M, pH 6.0) and 3 mL 0.1 M acetic acid, and 
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then dried under vacuum for 5 min at 400mmHg. After drying, wells were rinsed with 3 mL 
methanol. The wells were dried under vacuum for 10 min at 400mmHg. Basic analytes were 
eluted with 4mL 80:17:3 ethyl acetate/isopropanol/ammonium hydroxide. Extracts were then 
evaporated to dryness under a gentle stream of air (70°C) and reconstituted in 100 μL ethyl 
acetate for analysis by GC-MS.  
Extracts were analyzed on PerkinElmer Clarus 600C GC–MS (PerkinElmer LAS, Shelton, CT) 
using electron impact ionization, in the selected ion monitoring (SIM) mode. Separation was 
achieved using a ZB-Drug-1 column (30 m × 0.25 mm × 0.25 μm, Phenomenex, Torrance, CA). 
Extracts (2 μL) were injected into the injector, which was maintained at 250°C. The GC oven 
temperature was initially set to 60°C and held constant for 3 min. The set temperature was 
directly increased to 170°C at a rate of 130°C/min and then increased to 205°C at a rate of 
2°C/min. The oven temperature was then set to directly increase to 300°C and held at that 
temperature for 3 min at the end of the analytical run. The total GC–MS run time was 26 min. 
The ions monitored were m/z 180, 182, and 209 for KET (underlined ion used for quantitative 
analysis), m/z 166, 168, and 195 for NKET, m/z 153, 138 and 221 for DHNK, m/z 170, 172 and 
199 for NKET-d4 and m/z 184, 213, and 156 for KET-d4. The response ratio (RR) is defined as 
the ratio of peak area for the quantitation ion (m/z 180, 166 or 153) to that of the ion with m/z 
184 or 170 corresponding to KET-d4 or NKET-d4, respectively. NKET-d4 was used as the 
internal standard for DHNK. 
The limit of detection and quantification were 10 ng/mL KET and NKET and 25 ng/mL DHNK. 
Precision (%coefficient of variation, %CV of the ratio of measured responses of m/z 180(KET), 
166(NKET), DHNK (153), KET-d4 (184) and NKET-d4 (170) respectively) ranged from 2 to 
19%. This assay was shown to be linear for KET (R
2
 = 0.9978-0.9986), NKET (R
2
 = 0.9963-
0.9994) and DHNK (R
2
 = 0.9966-0.9990) for all standard curves prepared. 
2.2.5 MAE – Examination of Analyte Stability to Microwave Irradiation 
The solvents examined in the extraction of each drug were methanol (MeOH) and acetone: 
hexane (ACE: HEX, 1:1 v/v). The stability of each drug was examined under microwave 
irradiation in the presence of each solvent system. A solution of KET, NKET and DHNK (100 
and 1000 ng/mL) was prepared in each solvent (10 mL) and transferred to PTFE-lined extraction 
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vessels that contain 0.5g drug-free control bone. A magnetic stir bar was used in each extraction 
vessel to ensure sample agitation throughout the extraction. Each solvent and concentration 
combination was performed in triplicate with one solvent control. Extractions were performed by 
MARS 6 (CEM Corp., USA) at 80˚C (1200 W). For each sample, at a defined interval (0, 30 or 
60 min), 1 mL of solvent was removed. Prior to solvent removal, the vessels were cooled for 20 
min. After solvent recovery, each sample was evaporated to dryness to under a gentle stream of 
air at 70˚C. The samples were reconstituted in 1 mL PB6 (0.1M, pH 6.0), extracted by the 
MPSPE method described above and analyzed by GC-MS.  
2.2.6 MAE - Extraction Time Characterization 
Bone samples (0.5g) were transferred into PTFE-lined extraction vessels and 5 mL of extraction 
solvent (ACE:HEX, 1: 1 v/v) was added. A stirring bar was used in each extraction vessel to 
ensure constant sample agitation throughout the extraction. Analysis was performed in triplicate 
with one negative control. Extractions were performed by MARS 6 (CEM Corp., USA) at 80˚C. 
For each sample, at a defined interval (5, 10, 15, 20, 30, 45, or 60 min), the solvent was 
recovered and replaced with clean solvent in order to monitor the time required to achieve 
maximum extraction yield. Prior to solvent removal, the vessels were cooled for 20 min. After 
each solvent recovery, samples were washed once with 5 mL of extraction solvent and pooled 
with the original fraction. After sample recovery, all samples were evaporated to dryness under a 
gentle stream of air at 70˚C. The samples were reconstituted in 1 mL PB6 (0.1M, pH 6.0), 
extracted by the MPSPE method described above and analyzed by GC-MS.  
2.2.7     MAE - Effect of Extraction Solvent Volume on Extraction Yield 
Bone samples (0.5g) were transferred into PTFE-lined extraction vessels and 5 mL (n=3) or 10 
mL (n=3) of ACE:HEX (1:1 v/v) was added to each tube. A stirring bar was used in each 
extraction vessel to ensure constant sample agitation throughout the extraction. For each volume, 
triplicate analysis was performed along with one negative control.  Extraction was performed by 
MARS 6 (CEM Corp., USA) at 80˚C. For each sample, at defined intervals (5, 10, 15, 20, 30, 45 
or 60 min), the solvent was recovered and replaced with clean solvent in order to monitor the rate 
of extraction After each solvent recovery, samples were washed once with 5 mL of ACE:HEX 
(1:1 v/v) and pooled with the original fraction. After sample recovery, all samples were 
evaporated to dryness under a gentle stream of air at 70˚C. The samples were reconstituted in 1 
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mL PB6 (0.1M, pH 6.0), extracted by the MPSPE method described above and analyzed by GC-
MS.   
2.2.8 Passive Solvent Extraction 
Bone samples (0.5 g) were weighed into screw-cap test tubes and the appropriate amount of 
ACE:HEX (1:1, v/v) or methanol, 5 or 10 mL, was added. For each volume, triplicate analysis 
was performed with one negative control sample. Extractions were performed using a hot plate at 
50˚C. Each sample underwent 180 min passive extraction, with frequent vortexing to aid in 
analyte diffusion into bulk solvent. After sample recovery, all samples were evaporated to 
dryness under a gentle stream of air at 70˚C. The samples were reconstituted in 1 mL PB6 (0.1M, 
pH 6.0), extracted by the MPSPE method described above and analyzed by GC-MS.  
2.2.9 PSE - Bone Particle Size Comparison 
Two grinding systems were evaluated in terms of their extraction yield: Kitchen Aid coffee 
grinder and laboratory grade micromill and ball mill grinding system. Diagrams of bone particles 
from each grinding system can be viewed in appendix A. Bone samples (0.5g) were weighted 
into screw cap test tubes and the appropriate amount of methanol, 5 or 10 mL, was added. 
Analysis was performed in triplicate with one negative control for bones prepared with each 
grinding system. Extractions were performed on a hotplate set at 50˚C for 3 hours. Samples were 
frequently vortexed to aid in analyte diffusion. Following the extraction  period, solvent was 
recovered and samples were washed with 5 mL methanol and the two fractions were pooled. 
After sample recovery, all samples were evaporated to dryness under a gentle stream of ait at 70 
˚C, reconstituted in 1 mL PB6 (0.1M, pH 6.0) and underwent solid phase extraction as described 
above. 
2.3 Results and Discussion 
2.3.1 Expression of Drug Levels 
In this work, we report the drug levels as the mass normalized response ratios (RR/m) for KET, 
NKET and DHNK measurements, as we have done in various other reports (Watterson et al., 
2008, Watterson et al., 2011, Watterson et al., 2012). This is done because analyte recovery from 
solid bone tissue cannot be accurately measured using conventional techniques (i.e. GC-MS or 
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UHPLC) because solid bone sample is heterogeneous and cannot be homogenously mixed with a 
drug standard. The RR/m value is directly proportional to concentration and allows the 
comparison of drug levels between different experimental treatments. These values can be 
converted to estimates of concentrations however they should only be used as approximations 
due to the reasons stated above. 
2.3.2 Solid Phase Extraction Configuration and Chromatographic Conditions 
As part of our efforts to improve throughput in our laboratory, different configurations of SPE 
columns (with the same stationary phase) were evaluated in terms of precision, linearity, LoD 
and LoQ. For both the 16 column block manifold and the 48-well microplate, samples were 
prepared in 1 mL BTE at concentrations varying from 0 to 2000 ng/mL in replicate (n=3). Each 
configuration gave similar precision and linearity and the same LoD and LoQ. Due to the 
increase in throughput, 48-well microplate plates were used for all MAE experiments. Multiple 
gas chromatography conditions were evaluated to obtain optimal separation. The initial 
temperature of the second ramp was varied from 170-200˚C and the ramp rate was varied from 
2-6 deg/min. Based upon a standard mixture of the drugs in question, the ramps that had an 
initial temperature of 170˚C gave the greatest degree of resolution and had the best precision. 
These ramps were further tested with samples prepared in bone tissue extract at 3 concentrations 
(50, 500, 2000 ng/mL). Ultimately, the ramp with a rate of 2 deg/min gave the best degree of 
resolution and the best precision. Figure 2 shows the degree of resolution obtained with the 
optimized parameters. 
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Figure 2: Gas chromatography mass spectrometry total ion chromatogram of analytes in a 
standard solution. Labelled peaks correspond to ketamine (KET), norketamine (NKET) and 
dehydronorketamine (DHNK).  
2.3.3 Drug Stability under Microwave Irradiation 
The effect of microwave irradiation on each drug was investigated for each solvent. Figures 3 
and 4 summarize these results. Stability was assessed by preparing samples (n=3) of drug free 
bone in 10 mL extraction solvent spiked with each analyte at either 100 ng/mL or 1000 ng/mL. 
An aliquot (1 mL) of each sample was assayed before irradiation (t = 0 min), and after different 
periods of irradiation (30 or 60 min). In order to conclude that a given analyte was stable, the 
measured response ratio (RR±20%) was required to agree with RR (±20%) of the sample prior to 
irradiation (i.e., 0 min). For the drug standards prepared in methanol, the RR fell below the 
acceptable range after the 30 min time interval for samples prepared at 100 ng/mL and after 60 
min for the samples prepared at 1000 ng/mL for KET, NKET and DHNK. For the drug standards 
prepared in acetone: hexane mixture, no measured RR fell below the acceptable range, but a 
substantial increase in RR was observed in all samples after the first irradiation interval, and then 
fell back to within the acceptable range of values after 60 min irradiation. Overall, there was 
more evidence of analyte stability to microwave irradiation in the presence of acetone:hexane 
(1:1 v/v) than in the presence of methanol. Consequently, the extraction time and solvent volume 
required were subsequently optimized using acetone:hexane (1:1 v/v) as extraction solvent.  
 
 
NKET 
KET 
DHNK 
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Figure 3: Stability of ketamine, norketamine and dehydronorketamine in a methanol 
solution prepared at (A) 100 ng/mL and (B) 1000 ng/mL following exposure to microwave 
irradiation. Error bars represent standard deviation. 
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Figure 4: Stability of ketamine, norketamine and dehydronorketamine in an acetone: 
hexane (1:1, v/v) solution at (A) 100 ng/mL and (B) 1000 ng/mL following microwave 
irradiation. Error bars represent standard deviation. 
2.3.4  MAE - Extraction Time 
The time dependence of analyte extraction in ACE:HEX (1:1 v/v) was examined to determine 
the irradiation time required for routine extractions.  Samples (0.5g) of drug-positive (n =3) or 
drug-free bone (n = 4) were added to 5 mL ACE:HEX (1:1 v/v) in PTFE extraction vessels 
containing a magnetic stir bar. Samples were irradiated in short intervals, and after each interval 
all extraction solvent was removed, the bone washed with clean solvent that was then combined 
with the extraction solvent from that interval. Fresh solvent was then added to each bone sample 
and the next irradiation interval commenced. Extraction intervals of 5, 10, 15, 20, 30, 45 and 60 
min were examined. The solvent and wash samples recovered from each interval were then 
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assayed by the MPSPE-GC/MS method. KET and NKET were detected in these bones samples 
while DHNK was not.  The results are summarized in Figure 5. The data in figure 4 shows that 
the majority of each  analyte was recovered in the first 5 min of extraction. For KET, the entire 
extraction took 20 min to reach maximum extraction while NKET took 10 min to reach 
maximum extraction.  
 
Figure 5: Incremental recovery of ketamine (KET) and norketamine (NKET) from 0.5 g 
bone, in acetone-hexane (1:1, v/v). Recovery is expressed as the mass-normalized response 
ratio (RR/m), which is directly proportional to analyte concentration. Error bars represent 
standard deviation. 
2.3.5 MAE - Effect of Solvent Volume 
Two different solvent volumes (5 and 10mL) of ACE:HEX were examined to investigate their 
influence on the time required for extraction and relative recovery for each sample. Each set of 
samples underwent MAE for a total period of 60 min, with sequential recovery and analysis of 
the extraction solvent after each irradiation interval (5, 10, 15, 20, 30, 45 or 60 min). Relative 
recovery was measured by comparison of the total RR/m, summed over all extraction intervals, 
for each solvent volume examined.  KET and NKET were detected in these bone samples, while 
DHNK was not. For KET, extraction was complete within 15 min using 5 mL of ACE:HEX, 
while use of 10 mL extraction solvent resulted in a longer total extraction time (20 min). For 
NKET, the extraction time required was the same for both solvent volumes (10 min). For both 
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KET and NKET, there was no significant difference in total recovery between the different 
solvent volumes examined (p>0.05, U-test). Figure 6 illustrates the extraction profiles for KET 
and NKET in 5 and 10 mL extraction solvent following microwave irradiation.   
 
 
Figure 6: Extraction profile of (A) ketamine and (B) norketamine from 0.5 g bone, in 
various volumes of ACE:HEX (1:1, v/v) following microwave irradiation. Recovery is 
expressed as the mass-normalized response ratio (RR/m), which is directly proportional to 
concentration. Error bars represent standard deviation. 
2.3.6 Passive Solvent Extraction 
Different volumes of ACE:HEX and methanol were examined, to determine their influence on 
the extraction time required and net recovery. The total analysis time was 180 min with 
0
1
2
3
4
5
6
7
8
9
10
5 10 15 20 30 45 60
A
ve
ra
ge
 M
as
s 
N
o
rm
al
iz
e
d
 
R
e
sp
o
n
se
 R
at
io
 (
R
R
/m
) 
Time (min) 
5 mL
10 mL
A 
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
5 10 15 20 30 45 60A
ve
ra
ge
 M
as
s 
N
o
rm
al
iz
e
d
 R
e
sp
o
n
se
 
R
at
io
 (
R
R
/m
) 
Time (min) 
5 mL
10 mL
B 
34 
 
 
sequential recovery at various time points (5, 10, 15, 20, 30, 45, 60, 90 or 180 min). KET and 
NKET were detected in these bone samples, but DHNK was not. The majority of KET was 
extracted in the first 5 min for both solvents. KET had additional recovery up to 180 min. NKET 
was completely recovered in the first five minutes. There was no statistical difference in total 
recovery (p<0.05) between PSE and MAE for KET and NKET for each ACE:HEX and methanol 
volume examined. Figure 7 shows the extraction profile for KET and NKET in both solvents.  
Figure 8 shows the net recovery of each analyte undergoing PSE and MAE for each ACE:HEX 
volume examined.  
 
 
Figure 7: Extraction profile of KET and NKET in (A) methanol and (B) acetone-hexane 
(1:1, v/v)  from 0.5 g bone, in various volumes of ACE:HEX (1:1, v/v) following passive 
solvent extraction. Recovery is expressed as the mass-normalized response ratio (RR/m), which 
is directly proportional to concentration. Error bars represent standard deviation. 
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Figure 8: The net recovery of (A) KET and (B) NKET from 0.5 g bone in different volumes 
of ACE:HEX as a function of the method of extraction. Recovery is expressed as the mass-
normalized response ratio (RR/m), which is directly proportional to concentration. Error bars 
represent standard deviation. 
2.3.7 PSE – Bone Particle Size Comparison 
Two different grinding systems were examined to evaluate their effect on total extraction yield. 
Each set of samples underwent PSE on a hotplate for a total period of 3 hours. KET and NKET 
were detected in these bone samples but DHNK was not. There was no statistical difference in 
total recovery (p>0.05) between household coffee grinder and the laboratory grade micromill-
ball mill system for each volume examined. Figure 9 shows the net recovery of each analyte for 
both grinding systems and methanol volumes examined.  
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Figure 9: The net recovery of (A) KET and (B) NKET from 0.5 g bone in different volumes 
of methanol as a function of the grinding system. Recovery is expressed as the mass-
normalized response ratio (RR/m), which is directly proportional to concentration. Error bars 
represent standard deviation. 
2.4 Discussion 
2.4.1  Implications of Experimental Design and Results 
Skeletal tissues remain amongst the least understood biological matrices for toxicological 
analysis, although bone may be the only option for such analysis in death investigations 
involving severely decomposed remains. The processes by which drugs and metabolites 
distribute into, and are liberated from, bone are complex and vary depending on the anatomic site 
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of collection, the type of bone (cortical vs. trabecular) which influences the degree of 
vascularization and type of marrow (red vs. yellow) which is contained within, and the nature of 
the decomposition process (temperature, humidity, entomological activity, scavenging, etc.). The 
widely variable distribution of drug and metabolite concentrations between different bones in a 
given body (Watterson et al., 2010, Desrosiers et al., 2012, Watterson et al., 2012), in 
combination with these other processes, implies that a large database of bone tissue drug and 
metabolite measurements is necessary to develop models that may be useful to discriminate 
between different patterns of toxin exposure. Control of experimental environment and other 
variables such as dose and drug use history, in addition to providing for sufficient replication, 
requires that animal models be used in this work. As sample preparation is the most laborious 
aspect of toxicological analysis of bone, our laboratory is currently working towards 
streamlining of sample preparation processes to optimize analytical throughput. In this study, 
some experimental factors (extraction solvent, irradiation time and solvent volume) in 
microwave assisted extraction of ketamine and metabolites from ground bone were examined 
and compared to passive solvent extraction. Accordingly, a variety of bone types were collected, 
pooled and mixed thoroughly after pulverization in order to create as homogeneous a sample as 
possible for analytical method development and characterization. 
2.4.2 Stability of the Drugs in Microwave Exposure 
The effect of microwave irradiation was investigated for each standard drug solution, prepared in 
methanol or ACE:HEX, for 30 min and 60 min compared to samples that did not undergo 
microwave irradiation. The results of these experiments, displayed in figures 2 and 3, show that, 
in the case of methanol, the analytical response displayed a steadily decreasing trend for all three 
analytes. This result was somewhat surprising and the fate of the analytes under those conditions 
(i.e., chemical transformation, adsorptive loss, etc.) is not known at this time. Conversely, the 
analytes displayed an initial apparent increase in analytical response after the first 30 min of 
irradiation in ACE:HEX. While the small amount of solvent evaporation observed could not 
account for this change, the measurements after 60 min were in good agreement with analyte 
response prior to irradiation, so that no evidence of analyte loss was apparent with this extraction 
solvent system. Hence future work involving MAE of KET and its metabolites from bone will 
make use of ACE:HEX as the extraction solvent. 
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2.4.3 Extraction Parameters  
Figures 5 to 7 show that use of 5 mL extraction solvent with a 0.5 g sample of bone provided a 
good balance between analyte recovery and minimization of solvent use for both MAE and PSE. 
No improvement in analyte recovery was observed when 10 mL extraction solvent was used, and 
there was a slight increase in reaction time required in MAE, presumably due to the increase in 
thermal mass with the larger solvent volume. While the data might appear to suggest that KET 
was extracted more slowly than NKET, it is important to note that the extraction time required 
will be dependent to a large degree upon the analyte loading in a given bone sample. In this 
work, bones were obtained from rats that were euthanized shortly after drug exposure, resulting 
in a substantial excess of KET relative to NKET. Overall, the parameters examined here would 
yield successful drug recovery. Extraction methods should be developed separately for each 
solvent or solvent systems examined. As well, the extraction time should be as long as possible 
to obtain maximal drug recovery. In MAE, KET took at least 20 min to maximally extract from 
the bone samples; we feel that an overall 30 min extraction time at 80˚C is optimal. The 
additional 10 min of extraction time was added to allow more concentrated samples ample time 
to extract. In PSE, KET was maximally extracted in 180 min so we suggest that at least 180 min 
extraction time. The extraction temperature in PSE cannot exceed the boiling point of the solvent 
so a longer period is required for extraction. The bone analyzed here was pooled from a range of 
different bone types. This effectively dilutes the bone, relative to samples derived from sites 
known to have significantly higher analyte levels, such a vertebral or pelvic bone (Watterson et 
al., 2010, Watterson et al., 2011, Watterson et al., 2012). Sample size should be investigated as 
an additional extraction parameter in a case-by-case basis. With small animal models, 0.5 g is a 
reasonable sample size and constitutes the entirety of certain bone types (e.g., humerus). Tissues 
from humans or larger animals may be sampled in higher masses (>1-2 g), and may then require 
adjustment of extraction time to ensure maximum yields. 
2.4.4 PSE vs. MAE: Total Extraction Recovery 
Figure 8 shows the total recovery for KET and NKET using both extraction methods. These data 
show a tendency towards higher extraction recovery in MAE compared to PSE. KET showed 
higher or similar recoveries using MAE compared to PSE. NKET showed higher recoveries with 
MAE.  Based upon this data, MAE appeared to be giving a better total recovery. It is important 
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to remember that the benefits of MAE will depend upon the drug in question; however the results 
shown here indicate that MAE should be considered for the extraction of drugs from bone 
samples. 
2.4.5 Bone Particle Size Comparison 
Figure 9 shows the total recovery for KET and NKET using both grinding systems. The data 
shows that there is similar recovery between the two extraction methods for both grinding 
systems. The laboratory grade micromill-ball mill system produced a bone powder while the 
Kitchen Aid coffee grinder produced small chunks. It would be expected then, that the powder 
would produce a higher recovery due to its increased surface area. For the samples ground with 
the Kitchen Aid grinder, the large chunks were cortical bone and the powder was trabecular bone 
which absorbs the drug to a greater degree than the cortical bone (Watterson et al., 2008). 
Furthermore, if the drugs accumulate closer to the surface of the bone, further pulverizing will 
only expose the inner portions of the bone, which has accumulated a smaller degree of drug. 
2.4.6 Non-detection of DHNK 
As mentioned previously, one purpose of this work was to validate a method for the analysis of 
DHNK in bone samples. The validation data show that DHNK can be detected in bone tissue 
extracts with concentrations as low as 25 ng/mL. However, in the drug positive bone samples 
examined, DHNK was not detected. For this particular study, the bone samples examined were 
taken from a large mass that contained various types of bones. Because of this, the bone drug 
levels are diluted as drug distribution within bones depends upon the anatomical site (Watterson 
et al., 2008, 2010, 2011, 2012). Furthermore, DHNK is a minor metabolite of KET and in order 
for it to be produced, NKET must undergo degradation. The rats in this study were given an 
acute dose and with the half-life of KET being approximately 40 min in rats (Williams et al., 
2004); there was little time for NKET accumulation, which would, in turn, limit the amount of 
DHNK formed by metabolized. 
2.4.7 Benefits of MAE 
MAE provides a significant advantage in terms of extraction time and may improve overall drug 
recovery. The extraction methods reported to date, most by passive extraction or acid digestion, 
have used lengthy extraction times, ranging from 3 to 72 hours (McIntyre et al., 2000, 
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Gorczynski et al., 2001, Horak et al., 2005, McGrath et al., 2009, Desrosiers et al., 2012, 
Watterson et al, 2012,). Microwave assisted extraction has the ability to reduce extractions to as 
little as 5 minutes. However, this depends largely on the drug in question, choice of solvent, the 
amount of solvent used and the mass of tissue sampled. To date, most work in our laboratory has 
used extended passive methanolic extraction (Watterson et al., 2008, 2010, 2011, 2012), where 
24-72 hours was allowed for analyte extraction. In this work, maximum drug extraction was 
observed in 20 minutes for each of the conditions examined. Throughput was further enhanced 
with the microwave configuration used here by means of sample stirring and the capacity for 
simultaneous extraction of up to 40 samples.  
2.4.8 Conclusion 
The data presented here suggests that MAE may be an efficient methodology for toxicological 
analyses involving skeletal tissues. The optimum extraction procedure for KET and its 
metabolites required 30 min of microwave radiation in an acetone:hexane solvent mixture (1:1, 
v/v). Overall, experimental parameters such as extraction solvent, solvent volume and time 
should be optimized for each compound of interest as stability may vary. The extraction 
behaviour of drugs and  their metabolites as well as the ratio of parent drug and a given 
metabolite, may serve as an indicator of pattern of drug exposure (i.e. acute vs. repeated),  or 
time delay between drug exposure and death. This methodology is currently being applied to 
studies of the influence of body position and microclimate on ketamine and metabolite levels in 
various bone types.  
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Chapter 3 
3  The Influence of Body Position and Microclimate on Ketamine and 
Metabolite Distribution in Decomposed Skeletal Remains 
 
The influence of body position and microclimate on ketamine (KET) and metabolite distribution 
in decomposed bone tissue was examined. Rats received 75 mg/kg (i.p.) ketamine (n=30) or 
remained drug-free (controls, n=4). Following euthanasia, rats were divided into two groups and 
placed outdoors to decompose in one of three positions: supine (SUP), prone (PRO) or upright 
(UPR). One group decomposed in a shaded, wooded microclimate (site 1) while the other 
decomposed in an exposed sunlit microclimate with gravel substrate (site 2), roughly 500 m from 
site 1. Following decomposition, bones (lumbar vertebrae, thoracic vertebra, cervical vertebrae, 
rib, pelvis, femora, tibiae¸ humeri and scapulae) were collected and sorted for analysis. Clean, 
ground bones underwent Microwave Assisted Extraction (MAE) using acetone: hexane mixture 
(1:1, v/v), followed by solid phase extraction and analysis using GC/MS.  Drug levels, expressed 
as mass normalized response ratios, were compared across all bone types between body position 
and microclimates. Bone type was a main effect (p<0.05) for drug level and drug/metabolite 
level ratio for all body positions and microclimates examined. Microclimate and body position 
significantly influenced observed drug levels: higher levels were observed in carcasses 
decomposing in direct sunlight, where reduced entomological activity led to slowed 
decomposition.  
3.1 Introduction 
The use of bone as a toxicological specimen may occur in cases where blood, urine or liver 
samples are unavailable for analysis due to advanced decomposition. There have been numerous 
studies involving the detection of the drugs in bone tissue (McIntyre et al., 2000, Raikos et al., 
2001, Horak et al., 2005, McGrath et al., 2009, Watterson et al., 2010, 2011). These studies have 
used a variety of different skeletal tissues for analysis, and some only examined a small subset of 
tissues. Recent studies in our laboratory have examined a wide range of drugs (administered to 
rats under a range of conditions) in various skeletal tissues following decomposition (Lafreniere 
et al., 2009, Watterson et al., 2010, 2011, 2012, 2013). The analysis of these tissues showed 
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tissue dependence for the observed levels with highest levels generally observed in the central 
cavity (i.e. vertebrae, pelvis etc.) and lower levels observed in the humeri and scapulae. This 
distribution may be the result of differing amounts of trabecular bone content, different amounts 
of marrow in direct contact with the bone, or different degrees of drug adsorption from 
decompositional fluids following tissue liquefaction in the putrefaction process.  To date, there 
have been no studies investigating the influence of body position on the distribution of drugs in 
skeletal tissues after decomposition. If drug adsorption from decompositional fluids is one 
mechanism of drug deposition in bone, examination of drug levels in bone recovered from 
different body positions during decomposition may provide valuable insight as to where drug 
accumulation occurs under different conditions and provide further evidence for the ideal bone 
types for analysis.  
The effects of post-mortem environments on drug levels in skeletal tissues are also poorly 
understood. A small number of studies have examined assay response to bone tissue during 
burial (Gorczynski et al., 2001, Raikos et al., 2001, Guillot et al., 2007). They observed a 
difference in drug levels between samples that underwent burial and samples that did not. 
Midazolam, morphine, and 6-acetylmorphine showed higher drug levels in skeletal tissues not 
having undergone burial (Gorczynski et al., 2001, Raikos et al., 2001, Guillot et al., 2007). 
Another study showed burial effects to be drug and tissue dependent with Ketamine showing 
significant difference in observed levels while Diazepam did not (Desrosiers et al., 2010). No 
studies have examined the effect of differences in microclimate (i.e., differences in localized 
climatic conditions across short geographic distances) on detection of drugs in decomposed 
skeletal tissues. General decomposition studies have differing opinions as to which causes a 
faster decay rate, shaded areas (Galloway et al., 1999, Sharanowski et al., 2008) or sun-exposed 
areas (Shean et al., 1993, Majola et al., 2013). All of these studies showed a strong correlation 
between the decay rate and maggot activity (Galloway et al., 1999, Sharanowski et al., 2008, 
Shean et al., 1993, Majola et al., 2013). Studies have shown that maggots absorb and metabolize 
drugs from the substrates on which they feed and that concentrations of drugs detected in 
maggots were reflective of the total dose infused into that substrate (Miller et al., 1994, Gunn et 
al., 2006, Gosselin et al., 2010). These are important factors to consider in understanding the 
implications and limitations of using bone tissue for toxicological analyses. 
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In this study, differences in microclimate (i.e., differences in shade/sun exposure and 
surrounding flora over small geographic distances) and body position were investigated to 
determine their influence on ketamine (KET), norketamine (NKET) and dehydronorketamine 
(DHNK) distribution in decomposed skeletal tissues. Rats used in this study were given an acute 
dose of KET. Rats were divided into two groups and placed in a shaded/wooded or 
exposed/sunlit microclimate to determine if microclimate had a significant effect on the observed 
drug levels. Within each microclimate, rat carcasses were placed in one of three positions to 
decompose (supine, prone or upright), and examined to investigate if significant differences in 
observed bone drug levels were present. Bones underwent Microwave Assisted Extraction 
(MAE), solid phase extraction and were subsequently analyzed using gas chromatography-mass 
spectrometry, using methodology recently published (Cornthwaite et al., 2014).  
3.2 Methods and Materials 
3.2.1 Chemicals 
Methanol used in the drug extraction was HPLC grade and obtained from EMD Chemicals 
(Gibbstown, NJ). KET and NKET (Cerillant, Round Rock, Texas) were obtained as 1.0 mg/mL 
methanolic solutions and diluted as required. KET-d4 and NKET-d4 (Cerillant, Round Rock, 
Texas) were obtained as 100 µg/mL methanolic solutions and diluted as required.  DHNK 
(Cerillant, Round Rock, Texas) was obtained as a 100 µg/mL acetonitrile solution and diluted as 
required. Acetonitrile used was reagent grade and obtained from J.T. Baker (Center Valley, PA). 
All other chemicals were reagent grade and obtained from EMD chemicals. 
3.2.2 Animal Administration and Study Sites 
Male Wistar rats (n=30), weighing between 200 and 300 grams, were donated by Dr. T.C. Tai of 
the Northern Ontario School of Medicine. The rats received an acute dose of ketamine (75 
mg/kg, i.p.) and euthanized by CO2 asphyxiation within 20 minutes of drug administration. This 
dose was chosen as it is an anaesthetic dose in rats. Post-mortem, the rats were divided into two 
groups (n=15 per group),   each of which was further sub-divided into three groups based upon 
the position in which carcasses would be arranged during decomposition: supine - SUP (n=5), 
prone - PRO (n=5) and upright - UPR (n=5). Two drug free rats were also used as negative 
controls at each site. Each group of rats was placed outdoors at one of sites and allowed to 
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decompose to skeleton during the summer (Late June -July) with full exposure to weather 
features (sunlight, precipitation etc.). The two sites, one shaded/wooded with grassy/soily ground 
with extensive tree cover (site 1) and the other unshaded, with high direct sun exposure and 
gravel substrate (no underlying soil), situated on an elevated, rocky terrain with minimal 
vegetation (site 2) were located on the campus of Laurentian University in Sudbury, Ontario, 
Canada. At both sites, animals decomposing in the supine and prone positions were placed 
underneath wire mesh while animals in the upright position were set on pegs in cages for the 
duration of decomposition. Images of set-up and decomposition for both sites can be seen in 
appendices C and D. Site-specific climatic data was not recorded however daily average 
temperature and relative humidity readings were recorded and ranged from 10-27 
o
C and 59-
93%, respectively (data located in appendix B). Weather and the presence of insect activity were 
observed and noted. The carcasses at the shaded microclimate took 1 week to skeletonize while 
the carcasses at the unshaded microclimate took 4 weeks to decompose. After decomposition, 
bones collected for analysis included lumbar vertebrae (LVRT), thoracic vertebra (TVRT), 
cervical vertebra (CVRT) , ribs (RIB), pelvis (PEL), tibiae (TIB), femora (FEM), scapulae 
(SCAP) and humeri (HUM). 
3.2.3  Bone Preparation and Microwave Assisted Extraction 
Bones were separated according to type (e.g. femur, pelvis) and source animal (e.g. SUP-Animal 
1, UPR- Animal 4). Bones were washed sequentially with phosphate buffer (0.1M, pH 6.0), 
methanol and acetone to remove any loosely bound soil and other contaminants. Bones were left 
out to air-dry for 48 hours. Bones were ground using a two part system. First, a Micro-Mill (Bel-
Air Products, Pequannock, NJ) was used for 2min followed by a Ball Mill (SPEX Sample Prep., 
Metuchen, NJ) for 1min. Pulverized bone samples (0.5g) were weighed into PTFE-lined 
extraction vessels and 5mL of extraction solvent acetone:hexane (Ace:Hex, 1:1 v/v) was added. 
A laboratory grade microwave was used for the extractions with independent stirring in each of 
the 40 vessels to ensure constant sample agitation throughout the extraction. Extractions were 
performed by MARS 6 (CEM Corp., USA) at 80˚C for 30min. Prior to solvent removal, samples 
were cooled for 20min. After the extraction period, samples were washed with 5mL of extraction 
solvent and pooled with the original fraction. Samples were evaporated to dryness under a gentle 
stream of air at 70˚C, on a heating block, and reconstituted in 1mL PB6 (0.1 M, pH 6.0). 
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3.2.4 Solid Phase Extraction 
To each sample, internal standards [200ng KET-d4 and 200ng NKET-d4], 100µL glacial acetic 
acid and 3 mL acetonitrile: methanol (1:1 v/v) was added. Samples were stored at -20˚C for 12h 
to precipitate proteins and lipids. The samples were centrifuged (4000 rpm) for 10 min and the 
supernatant was collected and evaporated to 1mL under a gentle stream of air (70˚C). The 
samples were diluted to 4 mL with PB6 (0.1M, pH 6.0) and acidified with 100µL glacial acetic 
acid.  
Solid phase extraction was performed using CleanScreen XCEL 1 48 Well Plates (130 mg, 
United Chemical Technologies, Bristol, PA). Columns were first conditioned with 3mL 
methanol, 3 mL distilled water and 3 mL PB6. Samples were loaded on the columns and allowed 
to flow by gravity. The columns were washed with 3 mL PB6 and 3 mL 0.1 M acetic acid. The 
columns were dried using a vacuum pump for 5 minutes at 400mmHg. After drying, the columns 
were rinsed with 3 mL methanol. The columns were dried using a vacuum pump for 10 minutes 
at 400mmHg. The samples were eluted with 4mL 80:17:3 ethyl acetate/isopropanol/ammonium 
hydroxide. Extracts were then evaporated to dryness under a gentle stream of air (70°C) and 
reconstituted in 100 μL ethyl acetate for analysis by gas chromatography–mass spectrometry 
(GC–MS). 
3.2.5 Gas Chromatography Mass Spectrometry 
Extracts were analyzed on PerkinElmer Clarus 600C GC–MS (PerkinElmer LAS, Shelton, CT) 
using electron impact ionization, in the selected ion monitoring (SIM) mode. Separation was 
achieved using a ZB-Drug-1 column (30 m × 0.25 mm × 0.25 μm, Phenomenex, Torrance, CA). 
Extracts (2 μL) were injected into the injector, which was maintained at 250°C. The GC oven 
temperature was initially set to 60°C and held constant for 3 min. The set temperature was 
directly increased to 170°C at a rate of 130°C/min and then increased to 205°C at a rate of 
2°C/min. The oven temperature was then set to directly increase to 300°C at a rate of 60°C/min 
and held at that temperature for 3 min at the end of the analytical run. The total GC–MS run time 
was 26 min. The ions monitored were m/z 180, 182, and 209 for KET (underlined ion used for 
quantitative analysis), m/z 166, 168, and 195 for NKET, m/z 153, 138 and 221 for DHNK, m/z 
170, 172 and 199 for NKET-d4 and m/z 184, 213, and 156 for KET-d4. The response ratio (RR) 
is defined as the ratio of peak area for the quantitation ion (m/z 180, 166 or 153) to that of the ion 
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with m/z 184 or 170 corresponding to KET-d4 or NKET-d4. NKET-d4 was used as the internal 
standard for DHNK. 
3.2.6 Method Validation 
Samples of drug-free decomposed bone were sonicated in PB6 (100g in 500mL), after 
decomposition outdoors, to prepare the drug free matrix used in method validation. Samples 
were prepared in 1 mL of the calibrant at concentrations varying from 0 to 10000 ng/mL for 
KET and NKET, and 0 to 2000 ng/mL for DHNK in replicate analysis (n=3). They were 
subjected to the same steps (described above) as the MAE extracts drug-free and KET-exposed 
rats. The limits of detection and quantification were 10 ng/mL for KET and NKET and 25 ng/mL 
for DHNK. Precision was measured in triplicate analysis across 3 days (%coefficient of 
variation, %CV of the ratio of measured responses of m/z 180(KET), 166(NKET), DHNK (153), 
KET-d4 (184) and NKET-d4 (170) respectively) ranged from 2 to 19%. This assay was shown to 
be linear for KET (R
2
 = 0.9934), NKET (R
2
 = 0.9954) and DHNK (R
2
 = 0.9973). A sample of 
ethyl acetate was run following each concentration in one standard curve to evaluate the degree 
of carryover. At the all concentrations, the carryover was less than 10% of the smallest calibrator 
(10 ng/mL). Due to the presence of carryover, a sample of ethyl acetate was run after each drug 
positive sample. 
3.2.7 Gas Chromatography Mass Spectrometry Autosampler Stability 
The stability of the GC-MS response to KET and its metabolites was examined after the samples 
sat on the autosampler. Samples of KET, NKET and DHNK were prepared in 1 mL of bone 
tissue extract at two different concentrations, 100 ng/mL and 1000 ng/mL in triplicate. Samples 
underwent the same extraction procedure as described above, and were analyzed every six hours 
for a total of 48 hours while situated in the autosampler. For all analytes at both concentration 
levels examined, the analytical response remained within ±20% of initial values, indicating that 
samples were stable on the autosampler for up to 48 hr. 
3.2.8 Statistical Analysis 
All statistical analysis was performed using StatPlus 2009 software (AnalystSoft 
Inc.,www.analystsoft.com). The Mann-Whitney U-test, a non-parametric alternative to the t-test, 
was used to compare measured values (RR/m KET, NKET and DHNK) between different 
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environmental sites. The Kruskall-Wallis test, a non-parametric analysis of variance, was used to 
compare measured values (RR/m KET, NKET and DHNK) within one site across different 
decomposition positions. These nonparametric tests were chosen as they do not presume that 
measured values within a group are normally distributed. 
3.3  Results 
3.3.1 Expression of Drug Levels 
In this work, we report the drug levels as the mass normalized response ratios (RR/m) for KET, 
NKET and DHNK measurements. This has been described in a variety of published studies 
(Watterson et al., 2011, 2012, 2013) and is done because analyte recovery from solid bone tissue 
cannot be accurately measured or calibrated for using techniques conventional to forensic 
toxicology (i.e., GC-MS or LC-MS). Proper calibration of analyte recovery is not possible 
because the solid bone sample is heterogeneous and cannot be homogenously mixed with a drug 
standard for purposes of recovery measurements. However, the RR/m value is proportional to 
concentration and allows the comparison of drug levels between different experimental 
treatments using similarly prepared samples. These values can be converted to estimates of bone 
drug or metabolite concentrations, however they should only be used as approximations due to 
the reasons stated above. 
3.3.2  Influence of Body Position on Drug Distribution 
The influence of body position on KET, NKET and DHNK levels in decomposed skeletal 
remains was examined for each microclimate. KET and NKET were detected in all bone types 
examined at each microclimate. The average measured drug levels (i.e., RR/m) of KET and 
NKET are illustrated in Figures 10 and 11. The Kruskall-Wallis (KW) test was performed to 
determine whether bone type or body position during decomposition was a main effect for the 
observed drug levels of KET, NKET, DHNK as well as the ratio of levels of KET and NKET 
(RRKET/RRNKET), ratio of levels of KET and DHNK (RRKET/RRDHNK) and ratio of levels of 
NKET and DHNK (RRNKET/RRDHNK) within each site. Kruskall-Wallis analysis showed that 
bone type was a main effect for levels of   KET, NKET and (RRKET/RRNKET). For KET and 
NKET analyses, the body position during decomposition had a significant effect on the levels 
observed (p<0.05), except for the LVRT and HUM of site 2 for KET levels. The greatest KET 
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and NKET levels were generally observed in the SUP position for site 1 (shaded), whereas PRO 
and UPR positions were generally associated with higher drug levels for site 2 (sunlit), but drug 
levels appeared to be more similar between body positions at this site. Examination of the ratio 
of levels of KET and NKET (RRKET/RRNKET) for each bone sample also showed that the body 
position during decomposition was a main effect on observed values of (RRKET/RRNKET),  
(p<0.05), except in PEL of site 2. Average values for (RRKET/RRNKET) for each bone type are 
summarized in Figure 3 for each microclimate examined. 
DHNK was detected in only two bone types examined, lumbar vertebra and thoracic vertebra in 
both microclimates and average measured drug levels are summarized in Figure 9 and 10. KW 
analysis showed that bone type was a main effect for DHNK levels observed as well as the ratio 
of levels of KET and DHNK (RRKET/RRDHNK) and the ratio of levels of NKET and DHNK 
(RRNKET/RRDHNK). For DHNK analyses, as well as the analyses of the ratio of levels of KET and 
DHNK (RRKET/RRDHNK) and the ratio of levels of NKET and DHNK (RRNKET/RRDHNK), KW 
analysis showed that the body position during decomposing had a significant effect on the levels 
observed (p<0.05) except in TVRT in site 2 for the ratio of levels of NKET and DHNK 
(RRNKET/RRDHNK). 
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Figure 10: Average Mass Normalized Response Ratios (RR/m) of Distribution by Body 
Position for (A) Ketamine, (B) Norketamine and (C) Dehydronorketamine at the shaded 
microclimate. Error bars represent standard deviation. 
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Figure 11: Average Mass Normalized Response Ratios (RR/m) of Distribution by Body 
Position for (A) Ketamine, (B) Norketamine and (C) Dehydronorketamine at the sunlit 
microclimate. Error bars represent standard deviation. 
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3.3.3 Influence of Microclimate on Drug Distribution 
The Mann-Whitney test was used to assess differences in drug levels (RR/m) in each bone type 
between environments. For KET analyses, observed drug levels were significantly different 
(p<0.05) between environments in 7/9, 7/9 and 8/9 tissue types examined for SUP, PRO and 
UPR positions respectively with the greatest values generally observed in carcasses that 
decomposed in direct sunlight (site 2). For NKET analyses, observed drug levels were 
significantly different between environments in 5/9, 6/9 and 9/9 tissue types examined for SUP, 
PRO and UPR positions respectively with the greatest value, once again, in carcasses that 
decomposed in direct sunlight at site 2. Values of (RRKET/RRNKET) were significantly different 
between environments in 9/9, 6/9 and 9/9 tissues types examined for SUP, PRO and UPR 
positions respectively. 
DHNK analyses showed that drug levels were significantly different between sites in 2/2, 1/2 
and 2/2 tissue types examined for SUP, PRO, and UPR positions respectively, with the greatest 
SUP values observed in carcasses that decomposed in the shaded microclimate. The greatest 
PRO and UPR values were observed in carcasses that decomposed in direct sunlight. The ratio of 
levels of KET and DHNK and the ratio of levels of NKET and DHNK were significantly 
different in both tissue types examined, for all positions.  
Examination of data across all tissue types examined for each microclimate showed that drug 
levels varied 28-fold, 23-fold and 15-fold for KET, NKET and (RRKET/RRNKET), respectively for 
site 1 (wooded/shaded), and 56-fold, 43-fold and 20-fold for KET, NKET and (RRKET/RRNKET), 
respectively for site 2 (exposed/sunlit). The drug levels for DHNK, (RRKET/RRDHNK) and 
(RRNKET/RRDHNK) varied 8-fold, 25-fold and 3-fold respectively. Figure 12 shows box-and-
whisker plots depicting KET, NKET and (RRKET/RRNKET) levels corresponding to each 
microclimate.  
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Figure 12: Summary of pooled data for shaded and sunlit microclimates. Box-and-whisker 
plots for pooled bone samples for mass normalized response ratios (RR/m) for (A) KET, 
(B) NKET and (C) the ratio of levels of KET and NKET (RRKET/RRNKET).  
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3.4 Discussion 
This study is the first to examine the influence of body position and microclimate on skeletal 
drug distribution in following decomposition. Studies preceding this work have shown that 
toxicological analysis of bone is complex, although a dose-dependent response has been shown 
to exist in bone tissue (Watterson et al., 2011, 2012, 2013) although observed drug levels may be 
skewed as a result of decomposition (Lafreniere et al., 2009, Desrosiers et al., 2010). If drug 
adsorption from decompositional fluids is one mechanism of drug deposition in bone, it is 
important to examine whether environmental conditions that influence decomposition have any 
significant effect bone drug measurements. As decomposition proceeds, soft tissues liquefy 
which may result in drug partitioning from these tissues to the surrounding bone due to its 
somewhat porous nature. The amount of drug adsorption could be related to the surface area of 
contact between drug-rich fluid and the surrounding bone, the concentration of drug in decaying 
tissues (including marrow) and the amount of cortical or trabecular bone. Further, the position in 
which a body decomposed may potentially be influential as the effects of gravity would be 
expected to influence the contact between decompositional fluid and solid bone. 
3.4.1 Implications of Body Position Data 
Tissue type was a main effect for all drug level as well as the ratio of levels of drug and 
metabolite (RRKET/RRNKET, RRKET/RRDHNK and RRNKET/RRDHNK) in all cases. Figures 10 and 11 
summarize the average measured drug levels for KET, NKET and DHNK. Examination of KET 
and NKET levels across all bone types and all positions indicated that the highest levels were 
observed in SUP for the carcasses that decomposed in a shaded area. This was also the case for 
the ratio of levels of KET and NKET. In the SUP carcasses, pooling of the fluid from the 
liquefying tissues was observed in the central cavity which would provide more contact with the 
bone surface in the posterior regions of the body. The UPR carcasses began to sag in the first two 
days. As a result, the fluid from the liquefying tissues would have more contact with the ground 
then bone tissue. Interestingly, examination of Figure 10 shows that there is a shifting of the 
bone type with maximum drug levels from the vertebrae (as seen in the SUP samples) toward the 
pelvis and femur (as seen in the UPR samples).  The highest KET and NKET levels were 
observed in UPR for carcasses that decomposed in direct sunlight. The UPR carcasses were the 
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most dehydrated. This provided the greatest degree of contact between the liquefying tissues and 
the bone surface.  
The highest KET and NKET levels for each body position were the LVRT except in the case of 
KET in UPR carcasses in shaded microclimate which had higher PEL values. This lends some 
support to the notion that liquefying tissues may be one mechanism of drug transport into bone 
tissue. Vertebral bone is a likely candidate to absorb drug due to its high surface area and 
spongy, trabecular bone. In UPR, pooling would occur at the base of the carcass, femoral and 
pelvic regions would account for higher drug levels in these regions. 
DHNK was only detected in two out of the nine bone types examined, LVRT and TVRT. The 
extent of drug transfer to mineralized bone depends on multiple factors including: surface area, 
type of marrow and type of bone. Vertebral bone has a large surface area, red bone marrow, 
which is highly vascularized and is composed mainly of spongy bone. These facilitate a greater 
degree of mass transfer between the marrow and the mineralized bone. For these reasons, it is the 
type of bone mostly to absorb drugs and would provide detection of drugs with a lower 
concentration. The highest levels for DHNK, the ratio of levels of KET and DHNK and the ratio 
of levels of NKET and DHNK were similar to all drug levels; highest levels SUP for carcasses in 
shaded microclimate and UPR for carcasses in direct sunlight. The highest levels in each body 
position were TVRT for the carcasses in the shaded microclimate and LVRT for the carcasses in 
the direct sunlight microclimate. 
3.4.2 Implicates of Microclimate Data 
Microclimate significantly influenced levels for KET and NKET in 7/9 and 5/9, 7/9 and 6/9 and 
8/9 and 9/9 tissue types examined for SUP, PRO and UPR respectively. The ratio of levels of 
KET and NKET were significantly influenced by microclimate in 9/9, 6/9 and 9/9 tissue types 
examined for SUP, PRO and UPR respectively. DHNK was significantly influenced by in 5/6 
lumbar and thoracic vertebra samples examined for the three positions. The ratio of levels of 
KET and DHNK and the ratio of levels of NKET and DHNK were significantly influenced by 
microclimate in all tissues types examined.  In the cases of microclimate influence, the higher 
levels were generally found in carcasses that had been exposed to direct sunlight during 
decomposition. These remains were largely mummified, with a much lesser degree of 
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entomological activity to drive decomposition. Previous studies have suggested that dehydrating 
conditions at site 2 (direct sunlight and low humidity) are unsuitable for maggot activity 
(Galloway et al., 1999, Sharanowski et al., 2008). Others studies have shown that direct sunlight 
may act as a catalyst for stimulating maggot activity however in these cases, the carcasses were 
in environments with both high heat and high humidity (Shean et al., 1993, Majola et al., 2013). 
The slower rate of decomposition may have led to higher measured drug levels as a result of 
lesser drainage of decompositional fluids from the body and lower consumption of drug-laden 
tissues via insect activity.  The shaded carcasses had a much greater degree of maggot activity 
and subsequently a much faster rate of decomposition. Maggots have been shown to absorb and 
metabolize drugs (Miller et al., 1994, Gunn et al., 2006, Gosselin et al., 2010) which may 
account for the lower levels detected in the shaded carcasses. Also, these carcasses decomposed 
to skeleton in one week. As a result, there was little time for the liquefying tissues to interact 
with the bone surface and allow for drug adsorption to the bone surface. 
Overall, the wide variability in the data presented in this study and others (Watterson et al., 2011, 
2013) suggests that there may be limited interpretive value in quantitative measurements of 
individual drugs or metabolites. Without a large reference database encompassing drug levels 
from a variety of bone types and standardized methodologies, toxicological analysis of bone 
tissues remains best presented as a qualitative assessment. In this work we sought to examine the 
variability in individual drug and metabolite measurements as well as the ratio of levels of parent 
drug and metabolite, in order to determine if parent-metabolite ratio measurements were able to 
offset variability in drug or metabolite levels arising from differences in body position or 
microclimate during the decomposition process. Table I summarizes the variability, expressed as 
the ratio of maximum to minimum RR/m values (MAX/MIN), within a given bone type, across 
an animal and within a body position. As can be seen by examining the MAX/MIN values, 
variability in (RRKET/RRNKET) was comparable to that in levels of KET and NKET across an 
animal or within a position. However, in examining all bone measurements from each 
microclimate (Figure 4), (RRKET/RRNKET) values were less variable than either KET or NKET 
levels (MAX/MIN values of 28, 23 and 15, respectively, at site 1, and 56, 43 and 20, 
respectively, at site 2). Another important observation, consistent with what has been observed in 
previous work (Watterson et al., 2011, 2013) is that the relative variability within a bone type 
(i.e., across different animals) was generally lower than that observed across bones within an 
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animal, suggesting that drug level from one tissue type should be compared to a database of drug 
levels from that same tissue type if any interpretive value is to be gleaned.  
Table 6: Ratio of Maximum and Minimum Drug Levels (RR/m) For Ketamine and 
Norketamine at Each Body Position and Ratio of Maximum to Minimum Drug Level 
Ratios for Ketamine and Norketamine (RRKET/RRNKET) at Each Body Position for (A) 
Shaded Microclimate and (B) Direct Sunlight Microclimate. 
 
A 
Body Position Max/Min Range 
Within Given Bone 
Type  
Max/Min Range 
Within Animal 
Max/Min Pooled Bone 
and All Animals 
Ketamine (KET)    
Supine 1.2-1.6 9-17 18 
Prone 1.3-2.0 6-10 11 
Upright 1.2-1.9 3-6 6 
    Norketamine (NKET)    
Supine 1.2-2.3 3-5 6 
Prone 1.2-1.9 4-9 10 
Upright 1.2-1.8 3-6 7 
KET/NKET    
Supine 1.1-2.5 3-10 10 
Prone 1.2-1.9 7-10 13 
Upright 1.2-2.4 4-6 6 
 
B 
Body Position Max/Min Range 
Within Given Bone 
Type  
Max/Min Range 
Within Animal 
Max/Min Pooled Bone 
and All Animals 
Ketamine (KET)    
Supine 1.1-2.2 17-31 45 
Prone 1.2-1.9 21-47 49 
Upright 1.3-2.0 16-33 44 
Norketamine (NKET)    
Supine 1.2-1.9 9-14 19 
Prone 1.2-1.8 9-16 19 
Upright 1.3-1.8 16-40 40 
KET/NKET    
Supine 1.2-2.4 4-20 20 
Prone 1.2-2.1 3-4 5 
Upright 1.2-2.0 4-6 6 
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3.4.3 Conclusion 
This is the first environmental study that examined skeletal drug distribution under different 
influences of microclimate and body position during the decomposition process. First, drug 
distribution was found to vary between different body positions, potentially due to variation of 
the degree of contact between liquefying tissues and bone surface. Second, microclimatic 
differences (e.g., direct sunlight, humidity, temperature, etc.) that may affect the entomological 
activity around the remains are associated with variations in drug and metabolite distribution in 
bone. Similar studies should to be performed using other drugs to assess the general applicability 
of the data presented here. 
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Chapter 4 
 
4.1 General Conclusions 
A high throughput MAE and MPSPE protocol was developed for detection and quantification of 
KET and its two metabolites, NKET and DHNK. Analytes were extracted from bone in 30 
minutes using MAE with a similar recovery to PSE, which required 180 minutes for extraction. 
Secondly, the net recovery of analytes was similar for both grinding systems. Furthermore, 
microplate solid phase extraction proved to be a more efficient configuration then the block 
manifold. Using this protocol, influences of body position and microclimate were examined as 
they related to distribution in decomposed skeletal tissues. Observed KET and NKET levels were 
significantly different between body positions with the highest levels found in supine positioned 
rats for the shaded microclimate and upright positioned rats for the sunlit microclimate. In terms 
of microclimate, the sunlit region had much higher drug levels with substantially less maggot 
activity. Important to note, DHNK was only detected in two bone types: LVRT and TVRT. This 
may be attributed to the dose administered.  
4.2 Future Work 
Skeletal tissues are one of the least understood biological matrices available in forensic 
toxicology so further research is required. Generalized d rug extractions for classes of drugs 
should be developed. The research presented here, examines microclimatic differences that may 
affect drug distribution in decomposed skeletal tissues and is the first such study conducted in 
the forensic toxicology research lab (FTRL). This study was performed on a small scale to 
accumulate preliminary data. This type of study should be applied to a wide variety of drugs to 
access whether or not similar trends exist and on a larger scale. Furthermore, additional 
microclimates should be investigated. This study looked specifically at terrestrial decomposition 
however examination of aquatic decomposition and burial would provide a more complete 
decomposition profile. A partially shaded microclimate would be worth investigating to 
determine if the decomposition resembles the shaded or sunlit microclimates. For this particular 
study, temperature, humidity and rain fall data was collected from a weather network. In future 
studies, site specific and internal carcass temperature data should also be collected to correlate 
between sites and with weather networks. The season in which carcasses decompose should also 
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be considered. Finally, maggots, flies and beetles should be collected to determine their degree 
of influence on the observed drug levels. 
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Appendices 
 
Appendix A: Images of Bone Prepared with the Grinding Systems 
 
 
Figure A1: Bone Prepared with the Kitchen Aid Coffee Grinder 
 
 
Figure A2: Bone Prepared with the Micro-mill/Ball Mill Grinding System 
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  Appendix B: Temperature Data for Environmental Study 
 
Date 
Min Temp 
(˚C) 
Max Temp 
(˚C) 
Avg. Temp 
(˚C) 
Humidity 
(%) Weather  
15-Jul-13 16 31 24 66 
Sunny with Cloudy 
Patches 
16-Jul-13 17 33 25 67 Sunny 
17-Jul-13 21 33 27 78 Sunny 
18-Jul-13 18 27 22 85 Cloudy, Thunderstorm 
19-Jul-13 19 26 22 91 Cloudy, Rain 
20-Jul-13 13 21 17 68 Sunny 
21-Jul-13 6 21 14 62 
Sunny with Cloudy 
Patches 
22-Jul-13 9 25 17 64 
Sunny with Cloudy 
Patches 
23-Jul-13 9 23 16 77 Overcast, Mostly Cloudy 
24-Jul-13 6 21 14 64 Sunny 
25-Jul-13 9 23 16 69 Sunny 
26-Jul-13 11 23 17 69 Cloudy, Rain 
27-Jul-13 14 21 18 85 Overcast, Light Rain 
28-Jul-13 12 20 17 85 Cloudy, Rain 
29-Jul-13 9 19 14 87 Sunny 
30-Jul-13 8 24 16 78 Sunny 
31-Jul-13 12 24 18 84 Cloud Cover, Overcast 
01-Aug-13 13 22 18 87 Overcast, Rain 
02-Aug-13 11 20 16 93 Cloudy, Rain 
03-Aug-13 9 20 14 87 Sunny 
04-Aug-13 9 21 15 66 Cloud Cover 
05-Aug-13 7 21 14 69 Cloud Cover 
06-Aug-13 12 21 16 86 Overcast, Light Rain 
07-Aug-13 15 23 19 92 Cloudy, Rain 
08-Aug-13 12 22 17 77 Sunny 
09-Aug-13 9 19 14 84 Cloudy, Rain 
10-Aug-13 5 22 14 78 Sunny 
11-Aug-13 8 23 16 77 Cloudy, Rain 
12-Aug-13 10 22 16 86 Cloudy, Rain 
13-Aug-13 9 11 10 93 Sunny, Rain 
14-Aug-13 7 19 13 79 Cloud Cover 
15-Aug-13 8 22 15 73 Cloudy, Rain 
16-Aug-13 10 23 16 71 Sunny 
17-Aug-13 12 25 18 65 Sunny 
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Appendix C: Images from Shaded Microclimate 
 
      
 
Figure C1: Overall images of the shaded microclimate 
 
     
 
Figure C2: Set-up of rats in the supine position and degree of decomposition after 1 week 
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Figure C3: Set-up of rats in the prone position and degree of decomposition after 1 week 
 
     
 
Figure C4: Set-up of rats in the upright position and degree of decomposition after 1 week 
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Appendix D: Images from Sunlit Microclimate 
 
     
 
Figure D1: Overall images of the sunlit microclimate. 
 
     
 
Figure D2: Set-up of rats in the supine position and degree of decomposition after 4 weeks. 
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Figure D3: Set-up of rats in the prone position and degree of decomposition after 4 weeks. 
 
     
 
Figure D4: Set-up of rats in the upright position and degree of decomposition after 4 weeks 
 
